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ABSTRACT 
 
Johne’s disease (JD) caused by Mycobacterium avium subsp. paratuberculosis 
(MAP) is a contagious chronic enteritis affecting all ruminants and causing economic loss 
of at least $250 million annually in the US dairy industry. One of the major limitations in 
the diagnosis of JD is the low sensitivity of fecal culture in animals with no clinical signs 
of the disease, but who are actively shedding MAP. Persistence of MAP in the host with 
no apparent signs of infection is attributed to its ability to enter a dormant state wherein 
the bacterium is viable, but is not able to replicate until conditions become favorable. In 
vitro studies have shown that addition of culture media from starvation-dormant cells 
(SDCM) to growth media enhances the recovery of dormant cells. Resuscitative activity 
has been noted in the fraction of SDCM containing molecules equal to or smaller than 
5kDa in size; the ability of this fraction to resuscitate was resistant to heat and enzyme 
treatment.  
In this study we sought to further investigate the composition of low molecular 
weight fraction of SDCM in order to identify the nature of the molecules with 
resuscitative effect. Starvation-dormant MAP cells were grouped into three distinct 
phenotypes based on acid-fast staining properties, and fractions of SDCM were obtained 
from cultures of similar phenotype. Only higher dilutions of fractions pooled from 
cultures with preserved acid-fastness had a resuscitative effect, which disappeared with 
higher concentration of the fraction. Fractions derived from cultures with complete or 
partial loss of acid-fastness either had no effect or inhibitory effect on MAP recovery. 
The concentrates of resuscitative fractions were comparatively analyzed with non-
resuscitative fractions of SDCM, fractions of ADCM and growth media for 
protein/peptide concentration and lipid profile using BCA assay, SDS-PAGE gel 
electrophoresis, and thin layer chromatography. No proteins of 5kDa or smaller were 
detected in any of the samples. Resuscitative fractions of SDCM had a different mycolic 
acid profile compared to non-resuscitative, ADCM fractions, and cell-wall bound 
mycolic acids from exponentially growing MAP. Further analysis of lipid composition 
and lipid purification are needed in order to test whether lipids are involved in 
resuscitation of the MAP cells from the dormancy. 
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CHAPTER 1: INTRODUCTION 
Johne’s disease (JD), contagious chronic enteritis affecting most if not all 
ruminants, has been a burden for the dairy industry in the US (46, 47, 59) and across the 
world. It is caused by Mycobacterium avium subsp. paratuberculosis (MAP), a weakly 
Gram-positive acid-fast staining bacillus (69). Just as its notorious siblings, M. 
tuberculosis, M.leprae, and M. bovis, MAP persists in the host for years, provokes 
formation of granulomas, and is hard to eradicate. Once clinical symptoms develop such 
as decrease in milk production, intractable diarrhea, and wasting, the animal is considered 
to be fatally ill and is culled. MAP is primarily transmitted via fecal-oral route (48), 
animals being infected usually after ingesting contaminated by feces food or water. It has 
also been found in raw milk (30, 73), colostrum, and several studies have shown that it 
can be transmitted in utero (48) as well. Even though most of the animals get infected in 
calfhood, clinical symptoms usually develop in 2- to 5-year-old animals.  
Johne’s disease has a significant economic impact on dairy industry in the US (46, 
47) and across the world (26). The National Animal Health Monitoring System 
(NAHMS) reported that based on the study in 1996 herds with a high prevalence of 
Johne’s disease experienced an average economic loss of $227 per clinically diseased 
cow (80). Annual economic loss due to Johne’s disease in the US dairy industry is 
estimated to be at least $250 million (46, 81) and continues to grow. 
Besides being the cause of JD, MAP has been associated with a number of 
considered autoimmune or idiopathic at this moment human pathologies such as Crohn’s 
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disease (50), multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NOSD) 
(11). While MS and NOSD have been associated with increased numbers of antibodies to 
MAP peptides cross-reacting with human epitopes (11) and possibly causing the 
inflammatory reaction, Crohn’s disease is characterized by clinical and morphological 
picture very similar to JD. Many patients diagnosed with Crohn’s disease are indeed 
testing positive for MAP infection (50). Though it is not yet elucidated to which extent 
MAP contributes to the acquirement and/or exacerbation of the above mentioned 
diseases, early diagnosis of the infection and better understanding of the pathogen itself 
might be advantageous in preventing and/or management of these conditions. Reports 
detecting MAP in pasteurized milk (24, 60) question the safety of dairy products from 
diseased cows for human consumption. 
At the moment, there is no cure (48) for Johne’s disease, nor is there a vaccine 
that prevents infection with MAP (62). Therefore, early diagnosis is an important strategy 
for effective disease management. There are several tests available for detection of MAP 
infection; however, there is not a single ante mortem test that is both sensitive and highly 
specific. Up to this date, fecal culture remains the gold standard for MAP detection (88). 
The advantages of fecal culture are high specificity, cost-efficiency, and 
simplicity of the method. However, whereas in clinically diseased animals sensitivity 
approaches 100%, it drops to 30%-50% in asymptomatic animals (88). Animals with 
earlier stages of the disease are less likely to transmit MAP due to much smaller bacterial 
load shed with the feces compared to an animal with clinical disease (48); hence, early 
detection and isolation of infected animals can significantly reduce JD prevalence in the 
9 
 
herds. However, current fecal culture protocols often fail to recover MAP from animals 
in the early stages of JD resulting in false-negative test results. It suggests that like other 
pathogenic mycobacteria (1, 3, 44), MAP might enter a dormant state that allows it to 
persist in the host for years, but makes it difficult to recover the bacterium in culture. 
Dormant mycobacteria can revert to actively-growing state when conditions become 
favorable again leading to the progression of the disease. 
Based on the data acquired from studies on other pathogenic mycobacteria (1, 3, 
44) , it is possible that difficulties in isolation of MAP from animals in early stages of the 
disease resulting in low fecal culture sensitivity is due to the dormant state of the 
bacterium present in feces. Therefore, it is important to assure resuscitation of the 
dormant MAP to decrease the number of false-negative test results. Identification of 
growth-enhancing factors and supplementation with them of growth media might be a 
way to overcome culturing difficulties and increase test sensitivity. 
Studies on dormant M. tuberculosis have demonstrated the importance of Rpf 
proteins for reversion from dormancy (56, 93). It is predicted that Rpf proteins are able to 
break down peptidoglycan and possibly form second messengers (55) such as 
phospholipids, muropeptide Rv1174c and its cleavage products that have demonstrated 
resuscitative effect on dormant Mtb cultures (33, 92).  
Other studies showed that the Rpf proteins might be a part of a resuscitative 
cascade and are dependent on initiating stimuli. Lipids have been studied as potential 
signaling molecules in the resuscitative cascade (70, 92). The role of lipids in dormancy 
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and resuscitation has been investigated by several research groups noting differences in 
mycolic acid composition of cell wall of dormant mycobacteria (3) and changes of 
expression of genes involved in lipid metabolism in dormant state (8, 36). Involvement of 
lipids in resuscitation was demonstrated by growth-promoting effect of free fatty acids on 
dormant M. smegmatis (70). Due to genetic similarity of MAP to above mentioned 
mycobacteria (33, 43, 93), it is reasonable to assume that similar growth-promoting 
factors are involved in its resuscitation; however, it yet needs to be demonstrated. 
In vitro studies in our lab have shown that MAP is more likely to reverse from 
dormancy when a fraction of conditioned media (cell-free media from a previous culture) 
from starvation-dormant cells (SDCM) was added to the growth media (27). 
Resuscitative activity was noted in the fraction of SDCM containing molecules smaller 
than 5kDa in size, and the resuscitative effect of the fraction was resistant to heat and 
enzyme treatment (24) suggesting that a growth-promoting factor was not a protein, but 
not excluding the possibility of it to be a peptide or lipid. Similar fraction of conditioned 
media from anaerobically-dormant cells (ADCM) did not show any resuscitative activity 
(24, 27). Therefore, the goal of this research project was to comparatively analyze 
low molecular weight fractions derived from starvation-dormant and anaerobically-
dormant MAP in order to find differences in peptide and lipid composition. 
The objectives chosen to generate data to fulfill the above goal were to i) partition 
SDCM based on phenotype of dormant MAP culture determined by acid-fast staining and 
compare resuscitative effect of its low molecular weight fraction on anaerobically-
dormant MAP; ii) use SDS-PAGE gel electrophoresis, Biuret and bicinchoninic acid 
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protein assays to determine presence of peptides in the concentrates of low molecular 
fractions of SDCM and ADCM; iii) use thin layer chromatography to compare mycolic 
acid and glycolipid profiles of low molecular weight fractions of resuscitation-promoting 
fractions of SDCM  with other fractions of SDCM and ADCM. 
Characterization of the factors promoting resuscitation will aid in their precise 
identification. This in turn may allow for bioengineering of these factors and 
supplementation with them of growth media leading to increased sensitivity of fecal 
culture method for early detection of MAP infection. Early and improved diagnosis will 
reduce financial losses attributed to Johne’s diseases and will increase the safety of dairy 
and meat products for human consumption. 
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CHAPTER TWO: LITERATURE REVIEW 
2.1 Johne’s Disease 
2.1.1 History 
Johne’s disease (JD), also referred to as paratuberculosis, is a contagious, chronic, 
granulomatous enteritis affecting most if not all ruminants. It likely has been affecting 
wild and domesticated ruminants for centuries; however, it was first mentioned in the 
literature in 1826 by d’Aroval, who reported a specific type of enteritis in some cattle 
with chronic diarrhea. Later in 1881, Hansen and Nielsen described morphological 
modifications of intestinal mucosa associated with Johne’s disease, but it was not until 
1895 when Johne and Frothingham described the disease and identified the presence of 
acid-fast bacilli in the specimen from the diseased cow in Germany. Based on the 
morphology of the bacterium and its ability to provoke the formation of granulomas, 
Johne’s disease was mistakenly considered to be an atypical form of tuberculosis. 
However, after thorough evaluation of the disease, in 1906 Bang determined that 
Mycobacterium tuberculosis was not the causative agent and named the disease pseudo-
tuberculous enteritis or Johne’s disease (18, 48). In 1910 the etiological agent was 
isolated and named Mycobacterium enteriditis chronicae pseudotuberculosae bovis johne 
by Twort, and the disease often referred to as paratuberculosis. Since the year of its 
discovery the causative agent of Johne’s disease was referred to as Mycobacterium johnei 
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and Mycobacterium paratuberculosis; however, nowadays, an accepted name is 
Mycobacterium avium subsp. paratuberculosis, hereafter referred to as MAP (18). 
After the discovery of the first case in Germany, Johne’s disease was reported in 
Denmark, France, Norway, the Netherlands, Belgium, later on encompassing all of 
Europe.  The first documented case in the U.S. dates back to 1908 (14); since then 
Johne’s disease has been reported in all states in the US. Johne’s disease has been 
identified in Northern, Central and South Asia, Africa, Australia, New Zealand, South 
America. As of this date, it has not been reported in Antarctica (18, 48). 
2.1.2 Economic and environmental impact 
MAP can potentially infect all ruminants, including domesticated species such as 
cattle, goats, sheep, llamas, and wildlife species as deer, elk, etc. MAP can infect 
monogastric animals as horses, chicken, human and non-human primates as well. 
However, even though the bacterium is able to replicate, it rarely leads to progressive 
disease as in ruminants. Monogastric animals can still serve as shedders of MAP. Its wide 
host range makes it impossible to contain the disease; thus, the spread of the disease leads 
to economic losses and threat to biodiversity (32). The magnitude of economic loss 
depends on geographical region and its primary occupation. 
In the U.S. Johne’s diseases is the largest burden for dairy industry. As the disease 
progresses, the animals produce less milk, have to be prematurely culled, and the 
slaughter value is decreased (47, 59). The National Animal Health Monitoring System 
(NAHMS) reported that based on the study in 1996 herds with a high prevalence of 
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Johne’s disease experienced an average economic loss of $227 per clinically diseased 
cow. NAHMS also reported that in 1996, twenty-two percent of US dairy farms had at 
least 10% of infected with MAP cattle (80), whereas based on 2007 Dairy NAHMS study 
68% of dairy U.S. herds would report at least one MAP-positive animal. In large dairy 
herds, the prevalence of the disease would approach 100% (46, 81). Annual economic 
loss due to Johne’s disease in the US dairy industry is estimated to be at least $250 
million (47) and continues to grow. 
2.1.3 Stages of Johne’s disease 
Johne’s disease is a chronic disease with a slow course, with an incubation period 
ranging from less than 6 months to over 15 years. However, most often clinical 
symptoms develop in three- to five-year-old animals. Most of the animals get infected 
during calfhood and develop clinical paratuberculosis, described below, in 2-5 years. 
There has been an age-associated resistance to MAP noted, which might result from more 
mature immune system of adult animals. The course of the disease can be divided into 
four stages (17, 18, 32, 48). 
Stage I is referred to as the initial, silent stage. Animals do not show clinical signs 
and do not shed detectable numbers of MAP. Stage I will primarily be found in 
youngstock and might take years to slowly progress to stage II. 
Stage II, the subclinical stage, is characterized by healthy-appearing animals that 
shed low numbers of MAP. It is usually detected in older youngstock or mature animals; 
however, fecal culture or serologic testing is usually negative. 
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Stage III is considered to be clinical Johne’s disease; however, some animals can 
still appear healthy. Clinical symptoms characteristic for this stage include acute or 
chronic diarrhea, weight loss despite normal appetite and reduction in milk production. 
Animals shed more than 10
10 
colony forming units (CFU) of bacteria per gram of feces 
into the environment, thus greatly contributing to the spread of infection within the herd 
(48). Johne’s disease in stage III is often diagnosed clinically and easily confirmed by 
fecal culture or serologic testing. 
Stage IV, the terminal stage, is characterized by emaciation, intractable diarrhea, 
and bottle jaw. Animals are culled for slaughter at this stage; however, the slaughter 
value is often decreased due to wasting or concerns regarding safety for human 
consumption (14, 17, 48). 
When an animal in the herd is detected in stage IV of Johne’s disease, further 
inspection of the herd will detect more animals at different stages of the disease. This 
phenomenon is referred to as “The Johne’s Disease Iceberg” and depicts how Johne’s 
disease is a hidden herd problem and affects a few generations at once. For every animal 
in stage 4, it is estimated that there are 2-4 animals in stage III, 3-8 animals in stage II, 
and 5-10 animals in stage I. Unfortunately, available testing will most likely not detect 
animals stage I and II, thus, greatly undermining estimates of the prevalence of the 
disease in a herd (14, 18). 
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2.2 Mycobacterium avium subsp. paratuberculosis (MAP) 
2.2.1 Characteristics 
MAP, the etiologic agent of Johne’s disease, belongs to genus Mycobacterium, 
which includes weakly Gram-positive intracellular bacilli. MAP is 0.5µm in diameter and 
1.5µm in length, and is a non-motile, non-sporeforming, obligately aerobic bacillus (69). 
One of the distinctive characteristics of the genus is the presence of mycolic fatty acids in 
the cell wall of the microorganism, which is responsible for acid-fastness of the bacteria, 
confers resistance to harsh environmental conditions, and may explain the long-term 
persistence of the organism in the host and the environment. At the same time, the 
thickness and decreased permeability of the cell wall limits the access to the nutrients, 
which is reflected by the slow growth rate of pathogenic Mycobacterium species. While 
the majority of mycobacteria are saprophytic and are only opportunistic pathogens, M. 
tuberculosis, M. leprae, M. bovis, and MAP cause chronic disease and are hard to 
eradicate once in the host (14). All pathogenic species are considered slow growers, with 
generation times between 12 to 24 hours. MAP is considered to have the slowest growth 
rate among mycobacteria, with generation time over 20 hours. Visible colony formation 
on solid media such as Watson-Reid agar or Herrold’s egg yolk medium (HEYM) might 
require up to 4 months regardless the addition of various supplements and growth 
enhancing factors. MAP forms small, nonpigmented, rough colonies with complete 
margins and grows best at 37
o
C (14, 48). 
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Besides slow growth, MAP is also a fastidious microorganism requiring addition 
of mycobactin, a siderophore, for growth. Many bacteria depend on certain metals for 
growth; however, pathogenic mycobacteria require organic iron. Mycobactins, internal 
sequestering agents, and exochelins, the external vectors, are known bacterial 
siderophores and are responsible for chelating and transporting iron. Mycobacteria are 
unique by having both siderophores present; however, most if not all of MAP strains lost 
their ability to synthetize mycobactin for culture. It explains the failure in earlier attempts 
to isolate MAP from parasitized host tissues. Though MAP can grow and multiply freely 
in the host, it requires addition of mycobactin when propagated in vitro (48). 
Mycobactin-dependence used to be a key factor of identification of a mycobacterium as 
MAP; however, after isolation of other mycobactin-dependent M. avium strains (69), it is 
no longer a defining criterion for MAP identification. 
2.2.2 Classification 
With over 170 recognized species of Mycobacterium, MAP belongs to 
Mycobacterium avium complex (MAC) which in its turn includes Mycobacterium avium 
and its subspecies, as well as Mycobacterium intracellulare, Mycobacterium 
bouchedurhonense, Mycobacterium chimaera, Mycobacterium colombiense, 
Mycobacterium lepraemurium, Mycobacterium mantenii, Mycobacterium marseillense, 
Mycobacterium paraintracellulare, and Mycobacterium timonense (35, 69). There are 
four distinguished subspecies of M. avium: M. avium subsp. avium, M. avium subsp. 
hominissuis, M. avium subsp. paratuberculosis, and M. avium subsp. silvaticum (69). 
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As with other mycobacteria, MAP possesses key characteristics of the genus: 
acid-fastness, the presence of mycolic acids containing 60-90 carbon atoms, and genomic 
DNA having guanine + cytosine content of the DNA of 61 to 71 mol%. Being a 
subspecies of M. avium, MAP shares about 90% of the genome with other subspecies; 
however, it can be distinguished from other subspecies of M. avium by the presence of 
multiple copies of an insertion element, IS900, absence of IS1245 in its genome (43), and 
its requirement for mycobactin supplementation in order to grow in vitro. 
Molecular technologies applied in the last two decades allowed to distinguish two 
major groups of MAP strains: “Sheep-type” or “Type S” also referred as Type I and 
“Cattle- type” or “Type C” also referred as Type II. Original names for the types derived 
from the hosts of origin; however, they can be found in other mammals besides cattle and 
sheep. Each of the strains has multiple sub-lineages (74). MAP isolated from patients 
with Crohn’s diseases is grouped into Type C MAP (50). The two types can be 
distinguished from each other based on genomic variability due to specific large sequence 
polymorphisms (SNPs) including insertions, deletions, inversions, translocations, 
duplications, as well as host range, growth characteristics, and disease presentation. 
Generally, Type C is easier to isolate from clinical samples and can produce visible 
colonies in 4-6 weeks compared to Type S which takes 16 to 52 weeks to produce visible 
growth. Type S is also more sensitive to antibiotics including ampicillin and vancomycin, 
which might explain difficulties in its isolation (74). Normally, colony phenotype does 
not differ much between the strains, except that some strains isolated from sheep that can 
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produce yellow- or orange-pigmented colonies. Further genetic analysis of pigmented 
strains identified them as a sub-lineage of Type S (74). 
2.2.3 Genome 
The complete genome sequencing of MAP bovine isolate K-10 published in 2005 
shed some light on a number of unique characteristics of the bacterium. The MAP 
genome is presented as a single circular sequence of 4,829,781 base pairs and G+C 
content of 69.3%. MAP contains a single rrn operon (16S-23S-5S) compared to two sets 
found in fast-growing mycobacteria. The presence of a single rrn operon is also 
characteristic for M. tuberculosis, M. leprae, and M. bovis, which further explains the 
slow growth rate of the above mentioned pathogenic mycobacteria. MAP K-10 genome 
contains 4350 open reading frames (ORF), which indicates that about 91.5% of the 
genome is translated into protein. More than 68% of the genes are homologues of those 
found in the etiologic agent of tuberculosis, M. tuberculosis (Mtb) (43). 
The genome of MAP encodes for more regulatory genes than Mtb which might 
explain its ability to survive in a wider range of environmental conditions than Mtb. The 
dependence of MAP on mycobactin can be explained by a truncated form of mbtA, a gene 
in mbtA-J cluster that is responsible for mycobactin synthesis. 
The MAP genome contains genes for nearly all major metabolic pathways; 
however, it is lacking frdBCD, which encodes fumarate reductase; narX which encodes a 
positive regulator for nitrate reductase, and ureABC and ureDFG which encode urease. 
The absence of these genes in MAP helps to distinguish it from other MAC species. 
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MAP shares some of the proteins associated with immunogenicity and virulence 
with Mtb such as PE/PPE family of proteins, proteins thought to be expressed on the cell 
surface. However, whereas these proteins comprise 10% of Mtb genome, they only 
account for 1% of that in MAP. This observation may suggest a less variable immune 
response to MAP and the potential efficacy of vaccines directed against these proteins 
compared to Mtb (43). 
Another important gene related to pathogenesis is the mammalian cell entry (mce) 
gene, eight homologues of which were found in MAP. The mere presence of the gene 
does not confer pathogenicity as it is identified in non-pathogenic bacteria as well. 
A total of 39 predicted proteins are unique to MAP and are lacking homologues in 
currently available databases. These proteins may have potential value for diagnosis of 
MAP infection (43). 
Another distinctive feature of the MAP genome is the high number of repeat 
sequences and insertion sequences (IS) which serve as transposable elements. The MAP 
K-10 genome contains a total of 58 IS among which are 17 copies of the MAP-unique 
IS900, 7 copies of IS1311, and 3 copies of ISMav2. These sequences can serve as genetic 
markers of the bacterium (66, 75). 
2.2.4 Transmission and spread 
The route of transmission of MAP is mainly fecal-oral. Infected animals shed 
bacteria in their feces, contaminating the environment. MAP can survive in soil or water 
sources, thus, enabling the spread to new areas (89). An animal can get infected by 
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grazing in contaminated pastures or by drinking water containing MAP (48). It has been 
shown that MAP is present in raw cow milk (73) and colostrum, which may explain why 
most of the animals get infected in calfhood. It has also been shown that the offspring can 
get infected in utero. MAP may also survive milk pasteurization (24, 60), which might 
pose a threat of infection to humans. 
2.2.5 Immunology and pathogenesis of MAP infection 
The most common route of infection with MAP is through the gastrointestinal 
tract as a result of grazing in a manure-contaminated environment. Infective dose is 
believed to range between 10
3
 to 10
4
 MAP cells; however, clinical disease in sheep has 
been demonstrated with an infective dose of at least 10
8
 MAP. Susceptibility to MAP 
infection and the magnitude of the infective dose depend on type of host, its age and 
immunological status, microenvironment, and the strain of MAP. Younger animals are 
considered to be more susceptible due to the immaturity of their immune systems (17, 
32). 
MAP passes the epithelial barrier of gastrointestinal tract through microfold cells 
(M-cells) that uptake foreign organisms and antigens in order to pass them to dendritic 
cells, macrophages, B-cells for antigen presentation to T-cells residing in Peyer’s patches 
of the intestine. After being phagocytosed by a macrophage, MAP is not digested, nor 
does it lead to apoptosis of the macrophage (53). Like other mycobacteria, MAP is able 
to survive inside a macrophage by inhibiting acidification of phagosome and its fusion 
with the lysosome (40). Catalase and peroxidase are involved in neutralization of reactive 
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oxygen intermediates aimed to kill the bacteria, as well as alkyl hydroperoxidase 
reductase (AhpC), one of the major virulence factors of MAP, which inactivates both 
reactive oxygen and reactive nitrogen species (58). Thus, MAP provides for itself a 
shelter from circulating antibodies, NK-cells and T-cells by growing and replicating 
intracellularly. 
The initial immune response generated by MAP infection is believed to be Th1-
cell mediated, the goal being to kill the infected macrophage. However, failure to digest 
MAP or undergo apoptosis results in overproduction of cytokines such as IFN-ɣ, IL-1, 
IL-6, and tumor necrosis factor alpha (TNF-α) (64). Even though both serum and 
intestinal levels of cytokines are increased in subclinical animals, larger quantities are 
produced at the intestinal level. These cytokines are involved in granuloma formation, an 
attempt of the immune system of the host to wall off the infection and a pathognomonic 
sign of mycobacterioses. The expansion of these granulomas over time leads to 
establishment of cachexia (14, 48). Fluctuations in cytokine concentrations have a 
significant impact on the ability of MAP to survive intracellularly. Preincubation of 
murine macrophages with moderate levels of TNF-α (10 to 1,000 IU) improves survival, 
whereas higher doses of TNF-α (4,000 IU) significantly reduce bacterial numbers. 
Pretreatment of bovine monocytes with IFN-ɣ restricts intracellular growth of MAP (17, 
18, 48). 
Later in the course of the disease Th1-mediated immunity wanes and is replaced 
by Th2-mediated immune responses, with production of large amounts of anti- MAP 
antibodies. Unfortunately, since the pathogen is growing and replicating intracellularly, 
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these antibodies are of no use. Moreover, high titers of anti-MAP antibodies have been 
found in human patients with various autoimmune disorders suggesting that these 
antibodies might cross-react with host antigens (14, 18, 48). 
Morphologically, overproduction of cytokines leads to continuous inflammation 
and recruitment of macrophages, T-cells and B-cells to the site of the infection enabling 
the formation of granulomas. Often, infected macrophages fuse together to form 
multinucleated giant cells. Granulomas lead to the thickening of intestinal wall which in 
its turn causes the reduction in the surface area and decreased nutrient absorption (18). 
2.2.6 Survival of MAP in the environment 
A nationwide US study that used standardized environmental sampling indicated 
that 68% of American dairy herds are infected with MAP (46).  High herd prevalence of 
35% or more was also reported from the UK, the Netherlands, Canada, Denmark, Ireland, 
and Australia (26). Epidemiological data implies that in order keep continuous rates of 
infection, MAP must survive harsh environmental conditions. 
Multiple studies have shown that MAP can survive in highly alkaline 
environments (pH 12.4) for over 14 days, in feces -70
o
C for more than 15 weeks, and in 
infected tissues mixed with compost at 80
o
C for 90 days. MAP is somewhat sensitive to 
urine since it survives less than 30 days at 38
o
C in feces containing urine (89). This might 
be linked to a lack of genes encoding urease in the genome. Moist environment also 
favors MAP survival; however, viable bacteria can be found in dried feces after over 47 
months. MAP is more sensitive to direct sunlight, with several studies showing reduced 
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isolation of MAP in sunlight compared to organisms cultured from shaded environments. 
In case of MAP, it is believed to be the thermal flux from the sun rather than UV 
irradiation that has bactericidal effect (21, 89). MAP is also able to survive in sterile pond 
water over 9 months at room temperature and up to 163 days in a temperate climate (9). 
Environmentally, JD is more prevalent in the pastures with higher clay content in 
the soil as well as acidic soils; whereas, aridic climate and alkaline soils are less favorable 
for MAP isolation. Many farmers practice lime addition to the pasture lands to reduce JD 
occurrence (21). 
The ability of MAP to survive in such diverse and extreme conditions is attributed 
to the high content (60%) of mycolic acids in the cell wall that increase thickness and 
reduce permeability of damaging factors (89). However, the cell wall alone would not 
explain the ability of the bacterium to survive in nutrient-depleted conditions such as 
sterile pond water. Multiple studies have shown that MAP is able to enter a dormant state 
which allows it to survive without replicating (3, 89). Studies reporting formation of 
endospores by MAP failed to be replicated by other laboratories; however, a spore-like 
morphology of MAP has been described under nutrient starvation (41). 
The impressive resistance profile of MAP indicates that it can persist in water 
systems even pretreated with chlorine (9). The heat resistance of MAP also supports the 
potential of MAP to survive milk pasteurization (24, 60). Thus, there are multiple sources 
available for human infection. 
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2.3 Management of Johne’s disease 
Johne’s disease, once clinically manifested cannot be cured, nor can it be 
completely eradicated due to a very large host range including wildlife. Hence, the three 
major pillars in disease control are efficient management to decrease transmission, early 
diagnosis and culling, and vaccination (14). 
2.3.1 Vaccination 
Vaccination has been used as a tool for JD management since 1926 when Vallee 
and Rinjard developed the first vaccine consisting of a live non-virulent MAP and oil 
adjuvants (62). Since then many researchers directed their studies towards development 
of an effective live-attenuated vaccines. Live-attenuated vaccines are advantageous due 
to the cost efficiency of their production compared to subunit vaccines and their ability to 
generate both innate and adaptive immunity which can elicit protective response at the 
mucosal and systemic levels (28). Phage-mediated, transposon, and allelic exchange 
mutagenesis targeting virulence factors and genes necessary for survival is a commonly 
applied method for generation of attenuated bacterial strains. Examples of successful 
attenuated vaccine are ΔrelA mutant, WAg906 (ΔMAP1566), ΔleuD (22), ΔsigL (29), and 
ΔsigH mutants (28, 62). 
Recently, Johne’s Disease Integrated Program (JDIP) research consortium 
enforced a three phase vaccine candidate evaluation strategy. Phase I screens whether the 
vaccine candidate can induce monocyte derived macrophage (MDM) apoptosis; phase II 
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comprises a challenge test in a mouse model, and phase III evaluates the protective 
effects in a goat model (4, 62). 
 The biggest drawback of live-attenuated vaccines is their cross-reactivity with 
tuberculosis diagnostic tests and JD serological diagnostic assays. Thus, it might be 
challenging to distinguish whether positive skin tuberculosis test or JD serologic test is a 
confirmation of immunity or evidence of infection (39). 
In order to overcome disadvantages associated with whole-cell based vaccines 
that include live-attenuated and killed vaccines, subunit vaccines have come into the 
market. Well-defined recombinant MAP proteins or DNA encoding immunogenic 
antigens will be able to generate antibodies highly specific to MAP. Studies showing 
decreased intracellular MAP growth in presence of high concentrations of IFN-ɣ make 
identification of antigens able to induce a strong Th1 response a priority (4, 31,76). 
Several antigens were tested as potential candidates for subunit vaccines: heat shock 
protein 70 (Hsp70) (38, 65), antigen 85 complex proteins (Ag85A, Ag85B, Ag85C) (64), 
alkyl hydroperoxide reductases (AhpC, AhpD) (58), superoxide dismutase, lipoproteins 
(LprG, MAP0261c), and PPE family proteins (MAP1518, MAP3184) (31). The Hsp70 
vaccine demonstrated reduced bacterial load in vaccinated trial animals, lack of cross-
reactivity with tuberculosis skin test, and serologic JD test (38, 65). However, vaccination 
with the Hsp70 vaccine did not yield the expected high levels of IFN-ɣ inducing B-cell 
activation instead, which puts under the question the sole role of Th1-immune response at 
early stages of paratuberculosis (6). 
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DNA vaccines have been effective in mouse models, and also are easy to store 
and are very stable (34). Viral vectors have been used to increase antigenic effects of 
DNA vaccines and provide high delivery of antigens to antigen presenting cells (12). 
However, DNA vaccines have been only tested in a mouse model. MAP can infect and 
replicate in small rodents, however, it usually does not cause pathology similar to 
ruminant disease (18); hence, the results of the mouse model studies cannot be directly 
translated to ruminants and have to be validated in an appropriate host. 
At the moment, there are three commercially available vaccines, all three based 
on inactivated whole bacteria: Mycopar, Gudair, and Silirum (62). Only Mycopar 
(Boehringer Ingelheim Vetmedica Inc.) is approved for use in cattle in the United States 
and represents “MAP strain 18” which in fact is just a member of Mycobacterium avium 
species, but is not a MAP strain (62). Gudair (CZ Veterinaria, Spain) is based on heat 
inactivated MAP F316 strain adjuvanted with mineral oil and is used for sheep and goat 
vaccination. Gudair is used in Australia, however, longitudinal and cross-sectional 
studies produced unclear results regarding its efficacy (91). Silirum (Zoetis) is also based 
on MAP F316 and is recommended for cattle vaccination. Vaccination with Silirum led 
to reduction of the occurrence of clinical disease in farmed deer in New Zealand (26, 62). 
Despite availability of vaccines that do show at least some level of efficacy (4), 
vaccination is not often practiced. One of the reasons is severe tissue damage at the 
injection site (39); however, the usage of highly refined mineral oils in Silirum is aimed 
to reduce granuloma formation. The major problem remains the cross-reactivity of 
available vaccines with diagnostic tests for tuberculosis and JD (39). In order to 
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overcome this drawback or a subunit vaccine should be invented, or diagnostic tests 
should become more specific. 
2.3.2 Diagnosis 
Despite the fact that the etiologic agent of JD has been discovered over a century ago, 
there is not a diagnostic test which is both highly specific and sensitive. All the available 
diagnostic tests can be split in two groups: the ones identifying the causative agent, and 
the ones identifying immune response. Negative test results do not exclude the infection, 
whereas positive test results, while more valuable from diagnostic point of view, can be 
lacking in specificity. In order to increase the sensitivity and specificity of the tests, many 
of the assays are used in combination. Serial testing has also been practiced based on 
slow course of the disease (32, 48). 
2.3.2.1 MAP identification  
Direct stain 
Direct acid-fast staining can be done on feces in order to reveal mycobacterial 
bacilli. Ziehl-Neelsen or Wright’s staining can also be applied to slide impression smears 
from tissues collected at necropsy or through a biopsy of the ileum and mesenteric lymph 
nodes. Direct staining, though being a rapid, simple and inexpensive method, has a very 
low sensitivity and makes it challenging to distinguish MAP from saprophytic 
mycobacteria (48). 
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Culture 
Feces and tissue can be used to grow MAP in culture. MAP can grow in solid and 
liquid media as long as it is supplemented with mycobactin J. Commonly used media are 
Lowenstein-Jensen medium (LJ), Herrold’s egg yolk medium (HEYM), and Middlebrook 
medium often supplemented with antibiotics and/or other selective agents. Conventional 
culture method takes on average twelve to sixteen weeks to detect visible colonies (48). 
An alternative method is radiometric method of culture such as BACTECT 
460TB. Instead of detecting visible colonies, the system monitors sample-inoculated 
bottles with media for 
14
C-labelled metabolites produced by bacteria. A significant 
concentration of metabolites can be detected before the organism can form a colony, thus 
reducing detection time to as little as five weeks (90). Most radiometric methods use 
liquid media instead of slants, which also results in faster growth (30, 48). However, this 
type of testing can be performed only by specialized laboratories and requires handling 
and disposal of radioactive waste. 
Another automated mycobacterial detection assay is the mycobacteria Growth 
Indicator Tube (MGIT) system which contains enriched Middlebrook 7H9 broth base and 
silicone beads embedded with an oxygen-sensitive fluorochrome. When oxygen is 
abundant, e.g. sterile media, fluorescence is quenched. As MAP grows, it consumes 
oxygen, thus increasing fluorescence which can be detected by naked eye or BACTEC 
MGIT 960 instrument (30, 48). 
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Liquid broth-based tests yield faster results than those using solid media; 
however, one should not forget that other microorganisms also grow better in liquid 
media. Rapidly growing organisms present in feces and tissues can easily contaminate 
and overtake over slow growing MAP resulting in a false-positive test result. 
Fecal culture is considered a gold standard in MAP infection diagnosis, with 
specificity approaching 100% (88). However, since other mycobactin-dependent species 
of mycobacteria have been discovered, genotypic identification is recommended for the 
grown colonies. Despite high specificity, fecal culture has low sensitivity, which also 
varies based on the stage of the disease, host, and strain of the bacteria. It is also a very 
time-consuming process, which often needs to be repeated with a number of samples 
collected at different periods of time (68, 88). 
Genotypic identification 
Polymerase chain reaction (PCR) is used to amplify MAP DNA in clinical or 
environmental samples. The amplification target is usually unique to MAP insertion 
sequence IS900; however, IS900 closely related elements are present in other 
mycobacteria such as M. scrofulaceum, M. paraffinicum, M. marinum (48), thus, 
reducing the specificity of the method. Different primer sets and protocols can be 
employed in the diagnostic laboratories in order to overcome this problem, as well as 
probing for other targets such as IS1311, F57, ISMAP02, and ISMav2 (66, 73, 75). 
A triplex real-time PCR assay has been developed, which co-amplifies IS900, 
F57, ISMav2 using TaqMan fluorescent probes (66, 73, 75). This method can detect 
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MAP numbers as low as 10
2
 CFU per gram of feces with the accuracy of 70%. The 
triplex real-rime PCR was found to be more specific, as compared with conventional 
IS900 PCR (37). 
Multiple real-time PCR probing for MAP2765c (target 251) and MAP0865 
(sequence F57) genes (75) has been used for quantitative MAP detection in cattle gut 
tissue and in human tissue, and can be performed in less than 6 hours (16). Although 
specificity for multiple real-time PCR is higher, sensitivity usually decreases due to lower 
copy number of these targets compared to IS900. 
PCR-based methods, when performed on colonies isolated from sample, approach 
100% in both specificity and sensitivity. However, when applied directly to the sample, 
the effectiveness of PCR is significantly decreased due to diluted bacteria, presence of 
PCR inhibiting factors in feces or tissue, and microorganisms which might cross-react 
with probes (57, 61). Immunomagnetic separation, which is currently applied to milk 
samples, might improve the outcome of this method application (73). One should not 
forget, however, that PCR-based methods cannot distinguish between live and dead 
bacteria. 
Enzyme restriction fragment length polymorphisms (RFLP) have been studied in 
strains isolated from different hosts from different countries in order to establish a 
standardized system for DNA fingerprinting of MAP strains. A study of 1088 strains 
digested with endonuclease Pst I and Bst EII revealed 28 RFLP types with no relationship 
between RFLP type and host species (48). 
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Antigen 85- monoclonal antibody immunoassay 
Similar to hepatitis B surface antigen (HBsAg) detection widely used in screening 
for hepatitis B infection or immunity, an assay that can detect a unique MAP antigen 
would be a huge improvement in diagnosis. Antigen 85, a secreted product of replicating 
mycobacteria, though not unique to MAP, has been found circulating in blood, making it 
a good candidate for immunoassay (48, 64). Monoclonal antibody, which is highly 
specific for Ag85 and that can provide a sufficient level of sensitivity, will be able to 
detect infection without relying on immune response, which is the basis for currently 
available serologic tests. Immune response-based test results measuring the levels of 
cytokines or antibody titers vary depending on the stage of the disease and the ability of 
the host to generate a strong immune response. Most of the time, these are not very 
specific. 
2.3.2.2 Evaluation of immunological response 
Most infections cause the host to generate an immune response in order to fight or 
wall off the infection and prevent re-infection. It is usually manifested by increased levels 
of pro-inflammatory cytokines, clonal expansion of white blood cells, generation of 
antibodies with varying levels of specificity, recruitment of antigen presenting and 
immune cells to the sight of the infection, and cellular destruction via phagocytosis or 
apoptosis. Though there are trends in cytokine and antibody profile matched to certain 
agents, overall, those responses are not very specific with respect to MAP (48). Hence, 
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assays evaluating immune response are mostly applied for screening, and if positive, 
must be validated by a different test or histopathological and/or clinical findings (57). 
Assays evaluating humoral immunity 
There are three standard assays evaluating humoral immunity: agar gel 
immunodiffusion (AGID), complement fixation (CF), and enzyme-linked immunosorbent 
assay (ELISA) (48). Since their first application, many modified protocols and kits have 
emerged, but the principles remain the same. 
AGID represents “passive diffusion of soluble antigens and/or antibodies toward 
each other and their eventual precipitation in a gel matrix” that can be visualized and 
interpreted as positive or negative result. The AGID is applied for voluntary disease 
surveillance in cattle, sheep and goats. Reduced sensitivity compared to ELISA has been 
reported in cattle. In order to avoid false-negative results, larger amount of antibody has 
to be used in order to yield results comparable to those from ELISA. However, the AGID 
seems to have better specificity (48). False-positive results in ELISA are often due to 
cross-reaction with other microorganisms that have similar epitopes, e.g. 
Corynebacterium pseudotuberculosis (18, 57). 
The CF detects complement-fixing antibodies to MAP. The assay is often 
requested for international animal shipment health documents; however, both sensitivity 
and specificity of the test are lower than the AGID and ELISA (48). 
ELISA is a rapid inexpensive way to detect antibodies in serum or milk of the 
animal. Commercially available kits allow performing the test by ‘cow-side’ without the 
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need to contract a laboratory (48). ELISA, in general, has a higher specificity and 
sensitivity compared to other assays assessing humoral immunity. When performed on 
samples from an animal with clinical stage of the disease, sensitivity and specificity are 
approaching 100% (88). However, ELISA has a low sensitivity in subclinical animals. 
Another drawback is the abundance of false-positive results due to cross-reaction of 
antibodies with other microorganisms (57, 88). 
Assays evaluating cellular immunity 
Mycobacterial infection triggers a cell-mediated response that can manifest as 
delayed-type hypersensitivity reactions. Skin testing, especially in young cattle, has been 
used to detect early infection. A purified protein derivative (PPD) of MAP is injected 
intradermally, and skin thickening over 3mm within 24 h -72 h is suggestive of infection. 
However, the test has a low specificity since it often provokes cross-reactions with other 
mycobacterial species and MAP vaccinates. Many MAP infected animals will react with 
PPD-B, which is used to detect infection with M.bovis (39). The comparative cervical test 
(CCT), in which both PPD-B and M. avium tuberculin (PPD-A) are injected, can be used 
to distinguish MAP-infected cattle from those infected with M. bovis (48). 
An ELISA developed to measure concentration of a cytokine instead of an antigen 
is also among available diagnostic tests. It is used to determine the concentration of IFN-
ɣ, a cytokine which is produced in large amounts during cellular immune response (54, 
76). IFN-ɣ levels produced by peripheral blood leukocytes in response to stimulation by 
M. bovis antigens, M. avium antigens, and to a non-specific stimulant,  e.g. 
35 
 
phytoheamagglutinin,  are compared. The assay is commercially available; however, the 
low specificity and inconvenience of the assay limit its application (48, 57). 
Histopathological and clinical diagnoses are also widely used, but they cannot be 
applied to early detection of the infection. The gold standard of MAP infection diagnosis 
is necropsy with histopathological analysis of intestinal tissue and isolation of MAP (57). 
2.4 Dormancy 
2.4.1 Definition of dormancy 
The ability of MAP to persist in harsh environmental conditions, including the 
hostile environment of macrophages without a documented evidence of the ability to 
form spores suggests that, as with other mycobacteria, MAP can enter dormant state. 
Referred to by Wayne and Sohaskey as “non-replicating persistence” (NRP) (86), 
dormancy represents a reversible state of low metabolic activity which allows for survival 
of the microorganism without the need to replicate, and can be induced by unfavorable 
environmental conditions. The microorganism can revert to its actively-growing form 
once the conditions become again favorable for growth (44). Though dormancy is a 
viable state, dormant cells are often considered non-culturable due to difficulties 
associated with culturing these cells. 
2.4.2 Models of dormancy 
Dormancy and in vivo and in vitro dormancy model systems have been 
intensively studied for M. tuberculosis (Mtb) due to the tremendous clinical significance 
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of the organism and an important role attributed to Mtb dormancy in the pathogenesis of 
tuberculosis. Due to the genetic similarity between MAP and Mtb (33, 43) and related 
supporting experimental work, it is reasonable to assume that these models should also 
work to induce dormancy in MAP. Based on the in vitro nature of this thesis project, in 
vitro dormancy models will be briefly described. 
The first in vitro induced dormancy experiment was performed by Corper and 
Cohn in the 1920s. Mtb cultures isolated from humans were sealed and incubated at 37
o
C 
for 12 years, after which 0.01% viable organisms were isolated from the sediment of the 
bottles (1). Since then several models of induced dormancy have been developed based 
on three major pillars: gradual oxygen reduction also termed hypoxia, nitrous oxide 
treatment, or nutrient deprivation. 
The most frequently cited model of hypoxia-induced dormancy was described by 
Wayne and Hayes in 1996. In the original model, cultures were incubated without 
agitation. This resulted in the generation of an oxygen gradient between oxygen-rich top 
and anaerobic bottom, allowing bacteria to gradually adapt to microaerophilic conditions 
and survive (85). However, in order to approximate the model to in vivo occurrence and 
induce dormancy through a temporal rather than spatial gradient, the model was 
improved by incubating cultures with agitation. The major shortcoming of Wayne’s 
dormancy model is the lack of standardization and unexplained development of 
susceptibility to metronidazole (87) which was not found in in vivo experiments. 
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Starvation-induced dormancy was first published by Loebel el al. in 1932 (45); 
however, a modified Loebel nutrient-starvation model described by Betts et al. in 2002 
(8) became more applicable. Nutrient depletion may mimic the physiology of the 
microorganisms within granulomas, in which nutrients become scarce. This type of 
dormancy has been induced in vitro by transferring microorganisms from nutrient-rich 
medium into nutrient-depleted medium, usually phosphate buffered saline (PBS) (1, 8). 
Dormancy was achieved once the respiration rate decreased to a level that could maintain 
viability, but could not support replication. Dormant microorganisms were then 
transferred back into nutrient-rich medium, where reversion from the dormant state was 
observed. The model described by Betts yielded Mtb with similar antibiotic resistance 
profile as dormant Mtb in vivo and did not confer metronidazole susceptibility as did 
Wayne’s model (8). 
Other models use nitric oxide (NO), an antimycobacterial compound produced by 
activated macrophages, to reversibly inhibit aerobic respiration and growth. As such, this 
is the anaerobic dormancy model (84). Other modified protocols allow for the evaluation 
of dormancy based on color changes of the redox indicators, e.g. resazurin (77). 
 Dormancy models have also been tested on other mycobacterial species such as 
M. smegmatis, M. bovis, and were able to induce NRP (3, 55,70). 
2.4.3 Characteristics of dormancy 
Dormancy is characterized by a low metabolic and respiration rates, and an 
overall reduction in protein expression (3, 36). The low respiration rate results in 
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diminished production of reactive oxygen species and reduced need for catalase 
synthesis. The near shutdown of metabolism allows for survival in a nutrient-depleted 
environment. 
In the beginning of starvation-induced dormancy, lipid levels of normally lipid-
rich mycobacteria drop; however, their synthesis resumes as starvation progresses. Lipid 
catabolism is explained as the adaptation phase, and rebound of its synthesis is the result 
of cell reprogramming and the rearrangement of cell wall lipid synthesis, e.g. that of 
mycolic acids. Carbon and energy needed for cell wall lipid synthesis in the dormant state 
are presumed to come from previously stored glycogen and trehalose molecules (3). 
Prolonged starvation has qualitative and quantitative effect on mycolic acid 
synthesis, a major component of mycobacterial cell wall. There are three distinguished 
types of mycolic acids present in the cell wall: alpha mycolic acids, including at least 
70% of all mycolates, gamma (keto-) mycolic acids (15%), and beta (methoxyl-) mycolic 
acids (10%). During starvation, total mycolate synthesis decreases; however, keto-
mycolic acid synthesis is significantly increased, alpha-mycolic acid synthesis is also 
increased, but methoxyl-mycolic acid synthesis (responsible for wax ester formation) is 
slightly decreased. Keto-mycolic acids are straight-chain mycolates and can be more 
densely packed reducing cell wall permeability. Moreover, studies made on M. 
smegmatis showed that mycolates synthesized during starvation phase are modified 
during the synthesis, suggesting genetically reprogrammed mycolate class switching (3). 
Modifications in mycolate compositions might explain increased antibiotic resistance of 
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dormant mycobacteria through decreased cell wall permeability as well as overall 
increased resistance to hostile environments. 
Starvation can also affect morphology of mycobacteria, particularly their acid-fast 
property, due to an overall reduction of the mycolic acid layer. Lamont et al. reported 
formation of spore-like morphology type of MAP which survived exposure to heat, 
lysozyme, and proteinase K. This phenotype was enriched on sporulating media (Arret-
Kirshbaum agar), and transformed into acid-fast bacilli (41). However, sporulation in 
mycobacteria is a controversial topic and more data is needed to support sporulation as 
survival mechanism. 
2.4.4 Resuscitation 
Resuscitation is defined as the reversion from dormancy into an actively growing 
state, including the reconstitution of replication and metabolic activity. Whereas other 
bacteria use quorum sensing in order to regulate metabolism and population density 
control (63), this phenomenon has not been observed in mycobacteria. Studies trying to 
identify signaling molecules such as autoinducing peptides characteristic for Gram-
positive bacteria or N-acyl homoserine lactones (13) produced by Gram-negative bacteria 
were not fruitful, leaving room for research to identify the mechanism of resuscitation in 
mycobacteria (81). 
Several bacterial signals have been studied as putative signal molecules triggering 
resuscitation. The most well-researched signals at the moment are the resuscitation- 
promoting factor (rpf) genes which were first identified in M. luteus (55, 56) and later 
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found in other mycobacterial species including MAP (33, 93). Rpf genes (rpfA-E) were 
found to be necessary for resuscitation of Mtb, and, most likely, are functionally 
redundant and exhibit synergetic activity since deletion of at least several genes resulted 
in decrease of resuscitation. However, recent studies have shown that knockout of rpfD 
delayed reactivation in an in vivo murine model (82). The Rpf proteins most likely 
function intracellularly and exhibit properties of a dual lysozyme and lytic 
transglycosylase. Two of the Rpf proteins were predicted to be able to break down 
peptidoglycan and possibly form second messengers. These second messengers are 
thought to be phospholipids or muropeptides (55) such as Rv1174c isolated from Mtb. 
Peptide Rv1174c, 8kDa in size, had resuscitative effect on Mtb. Further proteolysis of 
Rv1174c yielded smaller peptides, 22 to 25 amino acid residues in length, which as well 
had resuscitative activity (92), suggesting that the small molecules can be the part of the 
resuscitative cascade. 
Other studies show that the Rpf proteins might need other stimuli to initiate the 
cascade. Shleeva et al. demonstrated in their study of M. smegmatis resuscitative role of 
free fatty acids (FAs) with one or more unsaturated bonds including arachidonic acids. 
The resuscitative effect was achieved only within an optimal concentration range of FAs, 
with higher concentrations demonstrating inhibitory and /or toxic effect via cell 
membrane disintegration (70).  
Another piece of evidence for the possible involvement of lipids in resuscitation is 
upregulation of lipY and lipX genes, encoding PE/PPE proteins, during resuscitation (36, 
67). This resulted in the change of cell wall lipid staining pattern (7). Interestingly, most 
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of the other genes upregulated in dormancy stayed upregulated through resuscitation (36). 
A number of studies showed specific changes in expression of DNA repair genes and clp 
protease genes in resuscitation. The transcription factor ClgR regulates expression of clp 
genes together with expression of other transcription factors such as sigH, sigE, dosR. It 
has been noted that sigH and sigE are upregulated during resuscitation (36, 49). 
Surprisingly, the same study showed that aerobic metabolism and ribosomal genes were 
not co- upregulated with the clp protease and DNA-repair genes (49), suggesting multiple 
stages for the resuscitative process.  
Most of the resuscitative studies were performed on Mtb or M. smegmatis, and 
even though MAP genome has homologs of above mentioned genes, their involvement in 
the resuscitation of dormant MAP remains to be demonstrated. 
Previous research in our lab has shown that conditioned media from starvation-
dormant MAP (hereafter referred as starvation-dormant conditioned media or SDCM) 
enhanced the resuscitation of anaerobically dormant and starvation-dormant MAP. 
Conditioned media derived from anaerobically-dormant MAP (ADCM) did not have 
effect on resuscitation (27). Further analysis of SDCM and its fractionation by 
ultrafiltration showed that only the fraction containing molecules of approximately 5kDa 
or less in size had resuscitative properties. The stability of resuscitative activity after 
treatment with high temperatures, digestive enzymes, and combination of digestive 
enzymes and heat favored the hypothesis that the molecule with resuscitative effect was 
not a protein (13), but this did not exclude the possibility of it being a peptide or lipid. 
Further analysis of the low molecular fraction of SDCM in comparison with ADCM will 
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help determine the nature of possible resuscitative molecule, and if identified, more 
targeted assays can be applied for its precise identification. Identification of resuscitative 
factors will allow to culture MAP even when dormant, thus improving the sensitivity of 
diagnostic fecal culture which in its turn will lead to better clinical and financial 
outcomes and better disease management. Hence, the nature of resuscitative properties of 
SDCM merits further investigation. 
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CHAPTER 3: MATERIALS AND METHODS 
3.1 Preparation and collection of conditioned medium from starvation-dormant 
Mycobacterium avium subsp. paratuberculosis (MAP). 
Mycobacterium avium subsp. paratuberculosis (MAP) PAMSUM8 (Minnesota 
State University, Mankato culture collection) was grown in M7H9C [Middlebrook 7H9 
broth (Becton Dickinson, Sparks, MD) supplemented with 10% oleic acid- 
albumindextrose-catalase (Becton Dickinson), 0.05% Tween 80 (Sigma, St. Louis, MO), 
and 2 µg of mycobactin J (Allied Monitor, Fayetteville, MO) per ml]. MAP (1 ml) was 
grown in 9 ml M7H9C at 37
o
C in sealed 25cm
2 
tissue culture flasks. Acid-fast staining 
was performed to check for contamination. After at least 8 months, MAP cultures were 
acid-fast stained again to check for contamination and cell morphology. Cells were 
harvested by centrifugation at 4192 x g at 4
o
C for 30 minutes. The supernatant was 
collected and filtered through a 0.22 µm filter. This filtrate was used as starvation-
dormant conditioned medium (SDCM) (27). The filtrate from the cells with similar 
morphology was pooled together and then transferred to Vivaspin 6 centrifugal 
concentrator with 5kDa ultrafiltration membrane cut-off (GE Healthcare, Little Chalfont, 
UK). The centrifugal concentrator was placed into collection tube and centrifuged in 
swinging bucket rotor at 2683 x g for 1 hour 45 minutes. The 5kDa ultrafiltrate then was 
syringe-filtered through 0.22 µm filter membrane into a sterile tube and stored at -80
o
C 
until further use (13). 
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3.2 Preparation of anaerobically-dormant responder MAP 
 Anaerobically-dormant MAP responder cells were prepared by inoculating 200 
µl of a mid- to late-exponential phase MAP into a 30 ml serum vial containing 20 ml 
M7H9C. The vial was closed with a rubber septum, sealed with an aluminum cap, and 
incubated at 37
o
C for at least 3 months. Before MAP responder cells were collected, the 
viability of the culture was measured using the LIVE/DEAD BacLightTM - Bacterial 
Viability Kit (Molecular Probes, Eugene, OR) (52). The kit contains SYTO 9, which 
fluoresces green when bound to DNA and is membrane-permeant (staining DNA in all 
cells); and propidium iodide (PI), which fluoresces red when bound to DNA and is 
membrane-impermeant (displacing SYTO 9 in dead and dying cells). To collect cells for 
the viability assay, 100 µl of the dormant culture were withdrawn from the culture vial 
with needles fitted to 3 ml syringes, then put in an Eppendorf tube (13, 27). The 
Eppendorf tube was centrifuged at 1817 x g for 30 minutes. The pellet was collected and 
washed in 1 ml filtered phosphate buffered saline (PBS). The suspension was centrifuged 
again at 1817 x g for 30 minutes, and the dormant cell pellet was resuspended in 1 mL 
PBS. Three microliters SYTO 9 (1.67mM): PI (1.67mM) were added to the bacterial 
suspension and mixed by vortexing for three-5 seconds. The cell-dye suspension was 
incubated for 15 minutes in the dark and then analyzed by flow cytometry (Guava 
Technologies, Millipore). The percentage of cells fluorescing green only was recorded as 
the percent viability of the dormant MAP responder cells. Cells with highest percentage 
of viable cells (≥ 50%) were used for resuscitative assays. 
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To collect anaerobically-dormant MAP responder cells, cultures were centrifuged 
at 1200 x g for 30 minutes at 4
o
C. Cell pellets were collected and suspended in 3 ml 
sterile PBS with 0.05% Tween-20 (PBST). Cell suspensions were adjusted to 30% 
transmittance at 490 nm, which was equivalent to 2 x 10
8
 CFU/ml. Tenfold serial 
dilutions of the adjusted bacterial suspensions were used to obtain dormant cell 
concentrations of 2 x 10
5
 CFU/ml in 10 ml of M7H9C (13, 27). 
3.3 Preparation of incubation chambers 
Two pieces of benzylkonium chloride-soaked paper were placed inside a plastic 
sandwich container. The container was then autoclaved at 121
o
C, 15 psi for 30 minutes 
and kept closed in a biosafety hood until use. To avoid contamination, the incubation 
chamber was exposed to UV light in the hood for 15 minutes prior to resuscitation assay 
setup or measurement of optical density (OD) (13, 27). 
3.4 Assay for resuscitative effect of low molecular weight fraction of SDCM 
Three twofold serial dilution of low molecular weight fraction of SDCM were 
prepared in M7H9C, and 100µl of 1:4 and 1:8 dilutions were added to hextuplicate wells 
of a 96-well microtiter plate. Anaerobically-dormant responder cells (100µl) were 
inoculated into all wells to a final concentration of 2000 CFU/well. Control wells 
contained only M7H9C and dormant responder cells (100µl of each), and blank wells 
contained only 200 µl of M7H9C. Microtiter plates were covered with a thin transparent 
polyester adhesive film (Whatman, Piscastaway, NJ) to minimize evaporation and 
contamination. The plates were then placed in the sterile plastic container and incubated 
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at 37
o
C for 15 days. Every two days, plates were allowed to equilibrate to room 
temperature, plastic seals were replaced to remove condensation, and OD590nm readings 
were obtained using a microplate reader (13). 
 All of the set up for resuscitation assays and preparation for OD measurements 
were performed aseptically in a biosafety hood. Fractions shown to promote a statistically 
significant increase in MAP growth compared to control were chosen for further analysis. 
3.5 Absorbance spectrum 
One hundred microliters of low molecular weight fraction of SDCM were 
analyzed across the entire wave length spectrum in order to determine the wavelength 
with most of the peaks. One hundred microliters of low molecular weight fraction of 
M7H9C were used as a blank. 
3.6 SDS-PAGE gel analysis 
Ten microliters of low molecular weight fraction of SDCM derived from cultures 
with different cell morphology, low molecular weight fraction of ADCM from three-
month-old and one-year-old cultures, and low molecular weight fraction of M7H9C were 
prepared according to commercially available protocol using Orange G as a gel loading 
dye and loaded on two separate SDS-PAGE Mini- PROTEAN Precast gels (Bio-Rad 
Laboratories Inc., Bulletin 1658100) (10). One of the gels was stained with Bio-Safe 
Coomassie Stain, while the other was stained with Promega Silver Staining Kit (Madison, 
WI) (2) in order to reveal proteins. 
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3.7 Biuret Protein Assay 
Samples of low molecular weight fraction of SDCM, ADCM, and M7H9C 
growth media, and bovine serum albumin were prepared according to commercially 
available protocol (25) in glass tubes. After 20 minutes incubation at RT, absorbance was 
measured at 540nm using a microplate reader. Protein concentration was calculated based 
on generated standard curve. 
 3.8 Bicinchoninic Acid (BCA) Protein Assay 
One milliliter of low molecular weight fractions of SDCM, ADCM, and M7H9C 
growth media was lyophilized. All the samples were resuspended in 100 microliters of 
water. Bovine serum albumin was used to prepare standard curve. The samples and the 
standards were prepared in quadruplicate and analyzed in a 96-well microplate following 
instructions from PierceTM BCA Protein Assay Kit, Thermo Scientific (78). Protein 
concentration was calculated based on generated standard curve. 
3.9 Thin Layer Chromatography (TLC) 
3.9.1 TLC for detection of fatty acid/ mycolic acid methyl esters 
Mycolic acids extracted from exponentially-growing MAP were used as a 
reference standard. MAP was inoculated in M7H9C [Middlebrook 7H9 broth (Becton 
Dickinson, Sparks, MD) supplemented with 10% oleic acid-albumindextrose-catalase 
(Becton Dickinson), 0.05% Tween 80 (Sigma, St. Louis, MO), and 2 µg of mycobactin J 
(Allied Monitor, Fayetteville, MO) per ml]. MAP (1 ml) was grown in 9 ml M7H9C at 
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37
o
C in sealed 25cm
2
 tissue culture flasks. Twenty five milliliters of exponentially-
growing MAP were harvested by centrifugation at 1509 x g for 10 minutes at room 
temperature. The supernatant was discarded, and the pellet was resuspended in 5mL of 
water and centrifuged again. The supernatant was discarded and the bacterial pellet was 
transferred to a round-bottom borosilicate glass tube with phenolic screw cap. One and a 
half milliliters of low molecular weight fraction of SDCM, ADCM, and M7H9C growth 
media were lyophilized and resuspended in 100 microliters of water and transferred to 
round-bottom borosilicate glass tube with phenolic screw cap. Two milliliters of 
tetrabutyl ammonium hydroxide (TBAH) were added to each tube, and the tubes were 
incubated overnight at 100
o
C in a heating block to allow for fatty/ mycolic acid 
hydrolysis. The next day, the tubes were allowed to cool down to room temperature and 
methyl esterification was achieved by adding to each tube 4mL of CH2Cl2, 300µl CH3I 
and 2ml of water. The tubes were mixed for 1 hour at room temperature (RT) on a 
rotator. The tubes were then centrifuged at 2054 x g for 10 minutes at RT, which 
separated the mixture into two phases. Upper phase was discarded, and 4mL of water 
were added to lower organic phase. The tubes were mixed for 15 minutes, followed by 
centrifugation at 2054 x g for 10 minutes at RT. The upper phase was discarded to waste, 
and the wash step was repeated two more times (20, 51). The lower organic phase then 
was dried by leaving the tubes open overnight in the fume hood. After the evaporation of 
the organic phase, 3mL of diethylether were added to each tube, and the tubes were 
sonicated in a water bath for 10 minutes at RT. The tubes were centrifuged at 2054 x g 
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for 10 minutes at RT, and the contents were transferred into a new glass tube (20). The 
diethylether was evaporated by leaving the tubes open overnight in a fume hood. 
The residue was resuspended in 100µl of CH2Cl2. Fifteen microliters of each 
sample were loaded on a plastic TLC silica gel plate (Analtech, Catalog #158017) using 
10µl capillary tube (Drummond Scientific). Fatty acid methyl esters (FAMES) and 
mycolic acid ethyl esters (MAMES) were separated by TLC using hexane/ethyl acetate 
(19:1, v/v) as the solvent. Once the solvent was 1.5cm away from the top of the plate, the 
plate was removed from the TLC tank, briefly dried, and placed back again for a second 
round of migration. After the second round of migration the TLC plate was allowed to 
dry, and then was sprayed with 5% ethanolic molybdophosphoric acid. The lipids were 
revealed by charring the plate with a heat gun until the bands became visible (20, 51). 
3.9.2 TLC for detection of glycolipids 
Glycolipids extracted from exponentially-growing MAP were used as a reference 
standard. MAP was inoculated in M7H9C [Middlebrook 7H9 broth (Becton Dickinson, 
Sparks, MD) supplemented with 10% oleic acid-albumindextrose-catalase (Becton 
Dickinson), 0.05% Tween 80 (Sigma, St. Louis, MO) and 2 µg of mycobactin J (Allied 
Monitor, Fayetteville, MO) per ml]. MAP (1 ml) was grown in 9 ml M7H9C at 37
o
C in 
sealed 25cm
2
 tissue culture flasks. Twenty five milliliters of exponentially-growing MAP 
were harvested by centrifugation at 1509 x g for 10 minutes at room temperature. The 
supernatant was discarded, and the pellet was resuspended in 5mL of water and 
centrifuged again. The supernatant was discarded and the bacterial pellet was transferred 
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to a round-bottom borosilicate glass tube with phenolic screw cap. Methanol was added 
at 10:1 of cell material weight (23). The contents were heated in a water bath at 65
o
C for 
5 minutes. After cooling to RT, chloroform was added to reach 2:1 chloroform: methanol 
suspension (42). The contents of the tubes were homogenized by sonication in a water 
bath at RT for 10 minutes (20). The samples were stirred at RT for 14 hours and then 
filtered to recover liquid phase (15). The solvent was washed by adding 0.2 volume of 
0.9% NaCl, vortexing and centrifuging at 1048 x g for 20 minutes. Upper phase was 
removed by pipetting as much as possible. The inside wall of the tube was rinsed with 
1.5mL of pure solvent upper phase (chloroform: methanol: water, 3:48:47, v/v; 0.29% 
NaCl) which was pipetted gently in order to avoid mixing interphase with lower organic 
phase. Remaining original upper phase and the rinse were removed, and the procedure 
was repeated twice. Lower phase and remaining rinsing phase were made into one phase 
by addition of methanol (23). 
Lipid solution was evaporated overnight in a fume hood. One and a half milliliters 
of low molecular weight fractions of SDCM, ADCM, and M7H9C growth media were 
lyophilized. All the samples were dissolved in chloroform, and 15µl were loaded on a 
TLC plate with a 10µl capillary tube. Chloroform/methanol/water (60:12:1, v/v) were 
used as a solvent. After the solvent reached the top of the TLC plate, the plate was 
removed from the TLC tank, was allowed to dry and sprayed with 0.5% α-naphthol 
dissolved in 50% methanol. After the first spray had dried, the plate was sprayed with 
50% concentrated sulfuric acid. The glycolipids were visualized by charring with a heat 
gun until the bands appeared (72, 83). 
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3.10 Data analysis 
All results from the resuscitative assay were entered into GraphPad Prism 
statistical software (La Jolla, CA) for data analysis. Each treatment, including serial 
dilutions, was graphed and compared to the control. One-way analysis of variance 
(ANOVA) was used to look for the significant difference among the means of different 
dilutions in a fraction for each day of the experiment. Two-way ANOVA was used to 
look for significant differences among the means of different dilutions of all fractions. 
Kruskal-Wallis tests were performed instead of ANOVA if the data were not normal. 
Dunnet’s multiple comparison test and Tukey’s Honest Significant Difference (HSD) test 
were used for post-hoc analysis of the data. Resuscitative effect was also assessed by 
analyzing whether a well reached optical density equal or greater than the mean of the 
control wells with three standard deviations added and maintained until the end of the 
experiment in order to correct for scanning error. 
Images of TLC plates and SDS-PAGE gels were analyzed with ImageJ software 
(NIH, Bethesda, Maryland). 
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CHAPTER 4: RESULTS 
4.1 The effect of dormant state on cell morphology 
Starvation-dormant MAP cells after 8-month-long incubation at 37
o
C were acid-
fast stained with Ziehl-Neelsen reagents in order to check for contamination and cell 
morphology. Short bacilli with tendency to clump were observed on all slides. However, 
three phenotypes were distinguished based on acid-fastness. Some bacteria preserved 
their acid-fastness completely; the second phenotype represented a mixture of acid-fast 
and non-acid-fast bacilli, but with identical morphology otherwise; the third phenotype 
lost its acid-fastness, but resembled acid-fast MAP in shape, size and tendency to clump. 
4.2 The effect of SDCM fractions from cells with varying morphology on 
dormant responder cells 
SDCM from 8-month-old MAP cultures was collected and pooled together based 
on phenotype of the culture it came from generating seven batches labeled T1, T2, T3, 
T4, T5, T6, T7. T1 and T7 were pooled from cultures that retained their acid-fastness 
properties; T3, T4, T5 were pooled from cultures with mixed phenotype; T2 and T6 were 
pooled from cultures of non-acid-fast MAP. Low molecular weight fractions of all 
SDCM batches were obtained by means of centrifugal filtration through a membrane with 
5kDa molecular weight cut-off (MWCO). Twofold serial dilutions of the low molecular 
weight fractions were prepared and tested for the ability to resuscitate three-month-old 
and 1-year-old anaerobically- dormant MAP. The optical densities at 590nm of responder 
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cells incubated with 1:8 dilutions of low molecular weight fractions of SDCM from acid-
fast cultures (T1, T7) increased with increasing time of exposure. The growth stimulating 
effect was significant by day 4 (p < 0.0001) for T1 and by day 10 (p < 0.001) for T7 in 
both three-month-old and one-year-old responder cells. Assessment of resuscitative effect 
of the fraction by the number of positive wells that maintained optical density three 
standard deviations above the average optical density of the negative control wells until 
the end of the experiment also supported growth stimulating properties of 1:8 dilutions of 
T1 and T7. A 1:4 dilution of T7 increased the optical density of one-year-old responder 
cells (p<0.001), but not of the three-month-old cells. However, assessment of the 
resuscitative effect by the number of positive  wells revealed only 2 positive wells out of 
6; hence, the resuscitative effect of 1:4 dilution of T7 was considered not significantly 
different from the control. 
Bacterial growth was inhibited compared to the control in wells treated with both 
dilutions of T5 and 1:4 dilution of T6 and T3 (p<0.05). Dilutions of other batches of 
SDCM yielded results that were not significantly different from the control (p>0.05). 
4.3 Absorbance spectrum of low molecular weight fraction of SDCM 
One hundred microliters of low molecular weight fraction of SDCM were 
scanned across absorbance spectrum in order to reveal a wavelength with a highest peak. 
One hundred microliters of low molecular weight fraction of M7H9C growth media were 
used as blank. The low molecular weight fraction of SDCM had the highest peak at 
220nm, small peak at 260nm, and no peak at 280nm.  
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4.4 Analysis of low molecular weight fraction of SDCM for presence of low 
molecular weight proteins/peptides or amino acid polymers via SDS-PAGE gel 
electrophoresis and protein staining 
Low molecular weight fractions of SDCM from T1, T2, T3, T4, T7, of ADCM 
from three-month-old and one-year-old cultures, and of M7H9C growth media were 
lyophilized and resuspended in smaller volume of water in order to generate 10X 
concentrates. The samples were loaded on SDS-PAGE gels using Orange G loading dye. 
The samples were stained with Coomassie Blue stain or silver nitrate in order to reveal 
proteins. No proteins of 10kDa or less in size were revealed in any of the samples. 
 4.5 Analysis of low molecular weight fraction of SDCM for presence of amino 
acid polymers via colorimetric techniques 
Biuret and microplate BCA assays were performed to determine protein 
concentrations of the samples with bovine serum albumin (BSA) used to build standard 
curve. Both assays detect the presence of peptide bonds in the samples compared to 
Bradford that measures the presence of aromatic rings such as tryptophan, tyrosine, and 
phenylalanine. The Biuret assay was performed on non-concentrated low molecular 
weight fractions of SDCM and ADCM from three-month-old and one-year-old cultures. 
However, the results of the assay were inconclusive due to inability to generate a working 
standard curve (R= 0.7144). The BCA microplate assay generated a working standard 
curve (R = 0.9879). Samples for BCA assay were lyophilized and resuspended in small 
volume of water in order to generate 10X concentrates. According to BCA assay, all the 
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samples including fraction from growth media contained significant amounts of protein 
(Table 4.1).  
Table 4.1 Protein concentration of 10X concentrates of low molecular weight 
fractions of SDCM, ADCM, and M7H9C growth medium determined by the 
bicinchoninic acid microplate assay (BCA). 
Absorbance, 
562nm 
T1 T2 T3 T4 T7 A3 A12 M 
Replicate 1 3.20 1.72 2.80 4.00 1.33 1.07 0.76 0.79 
Replicate 2 3.36 1.69 2.64 4.00 1.20 1.11 0.82 0.82 
Replicate 3 3.57 1.59 2.72 4.00 1.29 1.09 0.82 0.82 
Replicate 4 3.53 1.57 2.58 4.00 1.17 1.06 0.77 0.76 
Mean 
absorbance 
3.42 1.64 2.68 4.00 1.25 1.08 0.79 0.80 
[Protein], 
µg/ml 
3221.27 1449.5 2489.6 3805.2 1053.5 886.17 596.12 603.46 
 
T1, T2, T3, T4, T7 – low molecular weight fractions of SDCM from cultures with 
respective phenotype; A3, A12 - low molecular weight fractions of anaerobically- 
dormant conditioned media from three-month-old and twelve-month-old cultures, 
respectively; M – low molecular weight fractions of M7H9C growth medium 
supplemented with OADC. 
4.6 TLC for detection of fatty acid/ mycolic acid methyl esters 
Fatty acid methyl esters (FAMEs) and mycolic acid methyl esters (MAMEs) 
extracted from low molecular weight fractions of T1, T2, T3, T4, T7, ADCM ( three-
month- and one- year-old) and growth media were analyzed by TLC. FAMEs and 
MAMEs extracted from exponentially-growing MAP served as internal control. FAMEs 
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were present across all the samples including growth media. No MAMEs were detected 
in the growth media. All SDCM and ADCM samples had MAMEs present, but had 
different profiles. T1 and T7 had similar bands; however, bands in T7 were of lower 
intensity. MAMEs revealed in T1 and T7 were different from the ones present in 
exponentially-growing bacteria. Both samples of ADCM fraction had the same profile, 
but overall low concentration of MAMEs. Samples of SDCM from cultures with mixed 
phenotype (T3, T4) had identical profile and high concentration of MAMEs also found in 
internal control. Low molecular weight fraction of SDCM from non-acid-fast cultures 
(T2) had low concentration of MAMEs which differed from internal control and other 
fractions of SDCM and ADCM. Intensity of bands found on TLC was proportional to 
increase in protein concentration in BCA assay. 
4.7 TLC for detection of glycolipids 
TLC for detection of glycolipids revealed a band in internal control similar in 
migration pattern to lecithin, a phospholipid. Similar bands of a much lower intensity 
were observed in T1 and T7. Another band with a different migration pattern was 
detected in T1, but not T7. Glycolipids were detected in ADCM with a migration pattern 
more similar to phosphatidylethanolamine. 
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Figure 4.1 Three different phenotypes of 8-month-old starvation-dormant 
Mycobacterium avium susbsp. paratuberculosis (MAP) cells defined by Ziehl-Neelsen 
staining. A. MAP cells with preserved acid-fastness B. MAP cells with mixed phenotype 
C. Non-acid fast MAP cells. 
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Figure 4.2 High dilution (1:8) of a low molecular weight fraction of conditioned 
medium from starvation-dormant MAP cells with preserved acid-fastness (T1) 
enhances growth of three-month-old anaerobically-dormant MAP cells. Twofold 
serial dilutions of low molecular weight fraction of SDCM (100 µl) were added to 
microplate wells containing 100 µl (2000CFU/ml) of anaerobically-dormant 
Mycobacterium avium subsp. paratuberculosis. T1 represents low molecular weight 
fraction of SDCM from acid-fast cultures, T2 – from non-acid fast cultures. Plates were 
incubated for 14 days and growth was assessed by optical density measurements (590 
nm) every 48 hours at 590 nm. Control wells contained medium and dormant responder 
cells only. 
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Figure 4.3 High dilution (1:8) of a low molecular weight fraction of conditioned 
medium from starvation-dormant MAP cells with preserved acid-fastness (T1) 
enhances growth of one-year-old anaerobically-dormant MAP cells. Twofold serial 
dilutions of low molecular weight fraction of SDCM (100 µl) were added to microplate 
wells containing 100 µl (2000CFU/ml) of anaerobically- dormant Mycobacterium avium 
subsp. paratuberculosis. T1 represents low molecular weight fraction of SDCM from 
acid-fast cultures, T2 – from non-acid fast cultures. Plates were incubated for 14 days and 
growth was assessed by optical density measurements (590 nm) every 48 hours at 590 
nm. Control wells contained medium and dormant responder cells only. 
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Figure 4.4 High dilution (1:8) of T1 has a resuscitative effect on anaerobically-
dormant MAP cells. Positive well represents a well that reached optical density equal or 
greater than the mean of the control wells with three standard deviations added and 
maintained it until the end of the experiment. A. Resuscitative effect on three- month-old 
anaerobically-dormant responder MAP cells. B. Resuscitative effect on one-year-old 
anaerobically-dormant responder MAP cells. 
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Figure 4.5 Low molecular weight fractions of conditioned medium from starvation-
dormant MAP cells with mixed phenotype (T3, T4) do not improve the recovery of 
three-month-old anaerobically-dormant MAP cells. Twofold serial dilutions of low 
molecular weight fraction of SDCM (100 µl) were added to microplate wells containing 
100 µl (2000CFU/ml) of anaerobically-dormant Mycobacterium avium subsp. 
paratuberculosis. T3 and T4 represent low molecular weight fraction of SDCM from 
cultures with mixed phenotype. Plates were incubated for 14 days and growth was 
assessed by optical density measurements (590 nm) every 48 hours at 590 nm. Control 
wells contained medium and dormant responder cells only. 
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Figure 4.6 Low molecular weight fractions of conditioned medium from starvation-
dormant MAP cells with mixed phenotype (T3, T4) do not improve recovery of one-
year-old anaerobically-dormant MAP cells. Twofold serial dilutions of low molecular 
weight fraction of SDCM (100 µl) were added to microplate wells containing 100 µl 
(2000CFU/ml) of anaerobically- dormant Mycobacterium avium subsp. paratuberculosis. 
T3 and T4 represent low molecular weight fraction of SDCM from cultures with mixed 
phenotype. Plates were incubated for 14 days and growth was assessed by optical density 
measurements (590 nm) every 48 hours at 590 nm. Control wells contained medium and 
dormant responder cells only. 
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Figure 4.7 Addition of T3 and T4 fractions to the growth media does not improve 
recovery of anaerobically-dormant MAP cells. Positive well represents a well that 
reached optical density equal or greater than the mean of the control wells with three 
standard deviations added and maintained it until the end of the experiment. A. 
Resuscitative effect on three- month-old anaerobically-dormant responder MAP cells. B. 
Resuscitative effect on one-year-old anaerobically-dormant responder MAP cells. 
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Figure 4.8 Low molecular weight fraction  of the conditioned medium from 
starvation-dormant MAP cells  with mixed phenotype (T5) and 1:4 dilution of low 
molecular weight fraction from starvation-dormant MAP cells with the loss of acid-
fastness (T6) have inhibitory effect on recovery of three-month-old anaerobically-
dormant MAP cells. Twofold serial dilutions of low molecular weight fraction of 
SDCM (100 µl) were added to microplate wells containing 100 µl (2000CFU/ml) of 
anaerobically- dormant Mycobacterium avium subsp. paratuberculosis. T5 represents low 
molecular weight fraction of SDCM from cultures with mixed phenotype, T6 – from non-
acid fast cultures. Plates were incubated for 14 days and growth was assessed by optical 
density measurements (590 nm) every 48 hours at 590 nm. Control wells contained 
medium and dormant responder cells only. 
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Figure 4.9 High dilution (1:8) of low molecular weight fraction of conditioned 
medium from starvation-dormant MAP cells with preserved acid-fastness (T7) has 
resuscitative effect on three-month-old anaerobically-dormant MAP cells. Twofold 
serial dilutions of low molecular weight fraction of SDCM (100 µl) were added to 
microplate wells containing 100 µl (2000CFU/ml) of anaerobically- dormant 
Mycobacterium avium subsp. paratuberculosis. T7 represents low molecular weight 
fraction of SDCM from cultures with preserved acid-fastness. Plates were incubated for 
14 days and growth was assessed by optical density measurements (590 nm) every 48 
hours at 590 nm. Control wells contained medium and dormant responder cells only. 
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Figure 4.10 Low molecular weight fraction of conditioned medium from starvation-
dormant MAP cells with preserved acid-fastness (T7) has resuscitative effect on one-
year-old anaerobically-dormant MAP cells. Twofold serial dilutions of low molecular 
weight fraction of SDCM (100 µl) were added to microplate wells containing 100 µl 
(2000CFU/ml) of anaerobically- dormant Mycobacterium avium subsp. paratuberculosis. 
T7 represents low molecular weight fraction of SDCM from cultures with preserved acid-
fastness. Plates were incubated for 14 days and growth was assessed by optical density 
measurements (590 nm) every 48 hours at 590 nm. Control wells contained medium and 
dormant responder cells only. 
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Figure 4.11 High dilution (1:8) of T7 has resuscitative effect on anaerobically-
dormant MAP cells. Positive well represents a well that reached optical density equal or 
greater than the mean of the control wells with three standard deviations added and 
maintained it until the end of the experiment. A. Resuscitative effect on three-month old 
anaerobically-dormant responder MAP cells. B. Resuscitative effect on one-year-old 
anaerobically-dormant responder MAP cells. 
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Figure 4.12 Concentrated (10X) low molecular weight fractions of SDCM, ADCM, 
and M7H9C growth media analyzed by Coomassie Blue staining of SDS PAGE gel 
do not contain detectable levels of low molecular weight proteins/peptides. Low 
molecular weight fractions of SDCM from T1, T2, T3, T4, T7, of ADCM from three-
month-old and one-year-old cultures, and of M7H9C growth media were lyophilized and 
resuspended in smaller volume in order to generate 10X concentrates. The samples were 
loaded on SDS-PAGE gels using Orange G loading dye. The samples were stained with 
Coomassie Blue stain in order to reveal proteins. L – protein standard ladder; T1, T2, T3, 
T4, T7 – 10X concentrates of low molecular weight fractions of SDCM from cultures 
with respective phenotype; A3, A12 – 10X concentrates of low molecular weight 
fractions of anaerobically-dormant conditioned media from three-month-old and twelve- 
month-old cultures, respectively; M – 10X concentrate of low molecular weight fractions 
of M7H9C growth medium supplemented with OADC. 
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Figure 4.13 Chromatogram of fatty acid and mycolic acid methyl esters in 10X 
concentrates of low molecular weight fractions of SDCM, ADCM, and M7H9C 
growth media. FAMEs and MAMEs were extracted and analyzed by one-dimentional 
TLC using hexane/ethyl acetate (19:1, v/v, 2 runs) and revealed by spraying the plate 
with 5% molybdophosphoric acid followed by charring. S, FAMEs and MAMEs 
extracted from whole cell lysate of exponentially-growing MAP cells, served as internal 
control; T1, T2, T3, T4, T7 – 10X concentrates of low molecular weight fractions of 
SDCM from cultures with respective phenotype; A3, A12 – 10X concentrates of low 
molecular weight fractions of anaerobically-dormant conditioned media from three- 
months-old and twelve-months-old cultures, respectively; M – 10X concentrate of low 
molecular weight fractions of M7H9C growth medium supplemented with OADC. 
FAME, fatty acid methyl ester; MAME, mycolic acid methyl ester. 
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Figure 4.14 Chromatogram of glycolipids in the 10X concentrates of low molecular 
weight fractions of SDCM, ADCM, and M7H9C growth media. Lipids were extracted 
and analyzed by one-dimentional TLC using chloroform/methanol/water (60:12:1, v/v,  1 
run) and revealed by spraying with 0.5% α-naphthol in 50% methanol, then with 50% 
concentrated sulfuric acid followed by charring. PE, phosphatidyl ethanolamine; PCh, 
phosphatidyl choline, served as reference phospholipids; S, lipids extracted from whole 
cell lysate of exponentially-growing MAP cells, served as internal control. Arrows 
indicate visible bands. 
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Figure 4.15 Chromatogram of glycolipids in the 10X concentrates of low molecular 
weight fractions of SDCM, ADCM, and M7H9C growth media. Lipids were extracted 
and analyzed by one-dimentional TLC using chloroform/methanol/water (60:12:1, v/v,  1 
run) and revealed by spraying with 0.5% α-naphthol in 50% methanol, then with 50% 
concentrated sulfuric acid followed by charring. PE, phosphatidyl ethanolamine; PCh, 
phosphatidyl choline, served as reference phospholipids; S, lipids extracted from whole 
cell lysate of exponentially-growing MAP cells, served as internal control. Arrows 
indicate visible bands. 
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CHAPTER 4: DISCUSSION 
Ante mortem diagnosis of Johne’s disease is problematic due to low sensitivity 
and/or specificity of available assays, especially when testing animals in the subclinical 
stage of the disease (57). Fecal culture remains the most specific method of detection of 
MAP infection, with a relatively high sensitivity; however, the sensitivity of the assay 
drops drastically in animals with silent disease (88). Reduced sensitivity of fecal culture 
is believed to be due to inability to recover dormant organisms present in the specimen. 
Therefore, it is imperative to define the conditions that allow for the resuscitation of the 
dormant MAP in order to increase the sensitivity of the assay, improve disease 
management, and develop new diagnostic strategies. 
Previous work by Ghimire showed that starvation-dormant MAP secretes 
substances that enhance resuscitation of anaerobically-dormant responder cells (27). 
Further investigation by Cao identified that resuscitative properties were attributed to low 
molecular weight fraction (< 5kDa in size) of SDCM. The low molecular weight fraction 
of SDCM was able to induce resuscitation of responder cells on its own in a dose-
dependent manner; however, resuscitation was enhanced by the combination of the low 
molecular weight fraction of SDCM with fractions containing molecules ranging from 
10kDa to 30kDa in size. Resuscitative effect of low molecular weight fraction was not 
diminished by heat exposure and/or digestive enzyme treatment (13). The present work 
aimed to further characterize the composition of low molecular weight fraction of SDCM 
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in order to determine the nature of the resuscitative factor. We observed different mycolic 
acid compositions in the low molecular weight fraction of SDCM having a resuscitative 
effect, compared to similar-sized fractions of ADCM, growth media, and SDCM with no 
resuscitative effect. 
The phenomenon of dormancy has been observed in other mycobacteria, and 
potential resuscitative factors present in filtered conditioned medium have been 
described. The most studied resuscitation promoting factor is Rpf family of proteins with 
molecular weight of approximately 15-17kDa (56, 93). However, Cao’s study did not 
find resuscitative effect of SDCM fraction containing molecules within 10-30 kDa range 
in size (13). The present study also has not detected bands of 15-17kDa on SDS PAGE 
gels of 10X concentrates of low molecular weight fraction of SDCM, nor has it identified 
peaks absorbing at 280nm characteristic for proteins and aromatic compounds. The bands 
at approximately 70kDa detected in certain fractions are most likely due to contamination 
with bovine serum albumin during lyophilization process since they were not present in 
non-concentrated samples. Hence, Rpf proteins are most likely not responsible for the 
resuscitative effect seen with SDCM. 
A peak at 220nm observed in the absorbance spectrum of the low molecular 
weight fraction of SDCM suggested a peptide as a potential resuscitative factor. Zhang 
described resuscitative effect of Rv1174c peptide of 8kDa and its cleavage products of 
22-25 amino acids in length on dormant Mtb (92). A homologue of Rv1174c, MAP2609 
(GenBank accession number NP9615430) has been found in MAP genome. However, in 
silico digestion of Rv1174c or MAP2609 yields cleavage products of maximum 8 amino 
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residues in length (13, 33). Even though Cao’s data showed that low molecular weight 
fraction of SDCM did not lose its resuscitative effect after treatment with digestive 
enzymes (13), there is no data available supporting that a peptide that small can have a 
resuscitative effect. Moreover, there were no bands detected on SDS-PAGE gel of the 
10X concentrates of low molecular weight fractions of SDCM in 0-10kDa range, 
suggesting that peptides are not present in significant concentrations in the fraction of 
SDCM with resuscitative effect. Assays aimed to measure protein/peptide (Biuret and 
BCA assays) concentration based on peptide bond detection as well did not provide 
supportive data. Though based on the colorimetric data from both of the assays all of the 
fractions had significant amount of protein , both Biuret and BCA assays are susceptible 
to interfering agents such as ascorbic acids, lipids, cysteine, chelating agents, and agents 
with reducing potential (25, 78). Since other than ultrafiltration, samples were not 
purified and no significant bands were revealed on SDS- PAGE gels, high concentration 
of proteins suggested by BCA assay is most likely to be attributed to interference of other 
substances present in the fractions. Based on earlier findings and data obtained in the 
present study, it can be concluded that peptides are not likely to be responsible for the 
resuscitative properties of low molecular weight fraction of SDCM. 
Analysis of the low molecular weight fraction of SDCM across its absorbance 
spectrum revealed a peak at 220nm that is characteristic for a large number of organic 
compounds, including lipids and fatty acids. Considering that only SDCM fractions from 
cultures that preserved their acid-fast properties were able to enhance the recovery of 
dormant MAP cells, it is reasonable to speculate that a link exists between resuscitation 
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and lipid metabolism in starvation-dormant MAP. A closer look at lipid composition of 
outer membrane of mycobacteria shows that the most abundant lipids are free mycolic 
acids (MA) and fatty acids (FA), triacylglicerides (TAGs), and glycopeptidolipids (GPLs) 
which include 2.06%, 2.54%, and 5.56% of dry cell mass (dcm), respectively (5). All of 
the above-mentioned lipid compounds are less than 2kDa in size; thus, they can be 
present in the low molecular weight fraction of SDCM. 
It has been shown that starvation-dormant MAP cells indeed have a different cell 
wall mycolate composition with an increased proportion of more compact ketomycolates, 
which might decrease permeability and confer enhanced resistance to harsh 
environmental conditions and toxic agents (3). Zhang et al. explored the possibility of 
phospholipids serving as resuscitative factors for dormant mycobacteria. They provided 
data that the addition of phosphatidyl-L-serine, a precursor of phosphatydil ethanolamine 
and phosphatidyl choline, alone has a resuscitative and growth promoting effect. The 
resuscitative effect was abolished by treatment with phospholipase A2 and C (92). 
Glycopeptidolipids (GPLs) were reported to be involved in biofilm formation, which can 
enhance survival in nutrient-depleted conditions (9, 19). In the current study thin layer 
chromatography revealed the presence of glycolipids in low molecular weight fractions 
of SDCM derived from cultures that preserved acid-fastness, but not from cultures with 
mixed or non-acid-fast phenotypes. Both of the fractions with resuscitative effect had 
GPL bands that migrated similarly to phosphatidyl choline; however, one of the fractions 
also had a GPL with a different migration pattern. A glycolipid band was also observed in 
the low molecular fraction of ADCM, with migration pattern closer to phosphatidyl 
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ethanolamine. Since there has not been detected a precise pattern of GPL distribution 
among the fractions, it is unlikely that GPLs are responsible for the resuscitative 
properties of low molecular weight fraction of SDCM. 
Interestingly, mycolic acid methyl ester (MAME) composition differed among the 
low molecular weight fractions derived from CM of starvation dormant MAP cells with 
different phenotypes. Different MAMEs have also been detected in fractions derived 
from ADCM. It is worth mentioning that MAMEs found in CM fractions differed from 
the ones extracted from MAP whole cell lysates, suggesting that they are not cell wall- 
associated and are most likely secreted by the bacteria. 
The low molecular weight fraction of SDCM from acid-fast dormant MAP cells 
was able to promote resuscitation only at a higher dilution, which is consistent with the 
observation made by Ghimire (27). Shleeva et al. in their resuscitation study of dormant 
M. smegmatis and Mtb as well report that fatty acids were able to enhance bacterial 
growth only within the optimal concentration range, higher concentrations of FAs leading 
to cell membrane disruption and damage. In their study FAs mostly likely served as 
signal molecules that, when sensed by adenylyl cyclase, led to increase of cAMP which 
in turn upregulated expression of Rpf proteins by an as yet unknown pathway (70). Data 
obtained from the present study can be correlated with the observations made by Shleeva 
and her group. If mycolic acids are involved in resuscitation process, it is most likely a 
combination of a specific type of MA and its optimal concentration that have 
resuscitative potential. Based on the band intensity of detected MAMEs and using BCA 
assay data as indirect method of lipid concentration measurement, the samples with 
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highest concentration of MAMEs had inhibitory effect on MAP growth. Fractions that 
had resuscitative effect had comparable MAME concentration to non-resuscitative 
fractions; however, a different migration pattern of MAMEs was characteristic. 
There were a few limitations in the conducted study that might have affected the 
outcomes. First of them was the appearance of growth “spikes” in some of the optical 
density reads during resuscitative assays that did not continue in the following reading. 
The nature of “spikes” is unlikely related to the actual bacterial growth, but rather is 
caused by condensation or mechanical issues; however, it did generate larger standard 
deviation within the sample and complicated statistical analysis of the acquired data. 
Secondly, the experimental setup might not have been identical for all the 
samples. Due to the tendency of MAP cells to clump, it is difficult to inoculate wells 
evenly. Hence, reduced number of positive wells in certain fractions interpreted as lack of 
resuscitative activity might have been caused by suboptimal inoculation of other wells. 
Similar issues have been encountered by Cao (13) and protocol revision and/or 
modification need to be done in order to yield more reliable data. 
Another drawback of the study was the potential loss of mycolic acids and lipids 
during lipid extraction step for thin layer chromatography, which might have resulted in 
underrepresentation of lipid diversity and concentration in the samples. Large quantities 
of conditioned media are needed to correct this issue; however, due to time-consuming 
process of acquiring conditioned media from dormant cells, larger facility is needed. 
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Finally, even though presence of a significant amount of peptides/ amino acid 
polymers in the low molecular weight fraction of SDCM is unlikely, purification of 
samples from putative interfering agents in order to increase specificity of BCA assay is 
beneficial.  
Lipid involvement in resuscitation of MAP is a reasonable hypothesis for further 
investigation taking into consideration the results of the present study and supportive data 
from other research groups (70, 92). However, prior to considering it a primary driver of 
resuscitation induced by addition of low molecular weight fraction of SDCM to the 
growth medium, resuscitative role of other macromolecules should be assessed first. 
Shleeva et al. demonstrated that increase in cAMP levels on its own had a growth-
promoting effect on M. smegmatis (70). It is a fundamental knowledge that nucleotides 
have an indispensable role in metabolism and cell communication often serving as second 
messengers and/or energy blocks. Hence, nucleotides and cyclic nucleotides can be 
involved in resuscitation of dormant cells and need to be investigated. 
Another class of macromolecules that deserves attention is carbohydrates. 
Carbohydrates are linked to cell signaling, serve as receptors and energy source. Several 
studies demonstrated involvement of carbohydrate metabolism into dormancy and 
resuscitation of mycobacteria. It has been shown that dormant M. smegmatis has 
increased accumulation of free trehalose accumulation (64% of total organic substances) 
compared to early stationary phase (15% of total organic substances) (71). Dormant cells 
with higher free trehalose amount also survived much better compared to dormant cells 
with lower trehalose levels. Trehalose levels diminished during early resuscitation phase 
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suggesting their importance for the recovery of dormant cells (71). It is possible that 
besides just storing trehalose dormant mycobacteria can also secrete trehalose or other 
carbohydrate. Carbohydrates as well as nucleotides are potential candidates for the role of 
resuscitative factor in low molecular weight fraction of SDCM. A closer look at 
carbohydrate composition of the SDCM fractions might move some stumbling blocks in 
the understanding the mechanism of resuscitation of MAP or provide some supportive 
data to refute their involvement in the recovery of dormant cells. 
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CONCLUSION 
Dormancy has an effect on the lipid metabolism of MAP cells, particularly 
mycolic acids, that can be reflected in three phenotypes: dormant cells that preserve acid-
fastness, non- acid fast dormant cells, and intermediate mixed phenotype. 
Growth-promoting effect of conditioned media derived from starvation-dormant 
cells on anaerobically-dormant MAP cells suggests presence of resuscitative factors. 
Earlier studies defined them as molecules smaller than 5kDa in size, heat- and protease- 
(trypsin and thermolysin) stable, refuting the hypotheses of growth-promoting factors 
belonging to Rpf family of protein or being MAP2609, a homolog of Rv1174c found in 
Mtb. The absence of the peak at 280nm in absorbance spectrum and inconclusive Biuret 
assay and BCA assays results supported the hypothesis that resuscitative factors were not 
proteinaceous in nature. SDS-PAGE gel electrophoresis of 10X concentrates of the low 
molecular weight fractions of SDCM with further staining by Coomassie Blue stain and 
silver nitrate did not detect bands of 5kDa and smaller as well. 
Resuscitative effect was observed only from the low molecular weight fractions 
derived from cultures with preserved acid-fast properties, suggesting a link to lipid 
metabolism. Resuscitative effect was also observed only in higher dilutions of respective 
fractions, suggesting toxicity or inhibitory effect of factors found in CM at a higher 
concentration. 
Thin layer chromatography for glycolipids detected glycolipids in fractions of 
SDCM from acid-fast fractions and from fraction derived from anaerobically-dormant 
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cells, but no specific trend in glycolipid distribution was observed decreasing the 
likelihood of the role of glycolipids in resuscitation from the dormant state. 
TLC detecting MAMEs and FAMEs revealed different subtypes of mycolic acids 
depending on the phenotype of the culture the fraction was derived from. MAMEs 
detected in the fractions of CM differed from the ones extracted from MAP whole cell 
lysates, suggesting that they are not cell wall-associated and are most likely secreted by 
the bacteria. If mycolic acids are indeed involved in resuscitation of MAP from the 
dormant state, it is most likely a combination of a specific type of MA and its optimal 
concentration that have resuscitative potential. 
The present study, however, had a few limitations. Unexpected spikes of optical 
density were detected in many wells during resuscitative assay, which tended to 
disappear suddenly, suggesting that they were not related to the actual MAP growth. The 
tendency of MAP to clump also could have affected the ability to inoculate the wells with 
equal amounts of bacteria. Both of the issues might have had an effect on statistical 
analysis of the data and were responsible for high standard deviations. 
Complicated extraction protocols for TLC samples could have resulted in 
significant loss of the sample and hence incomplete data. However, significantly larger 
amounts of bacteria have to be grown to overcome this problem, which is time-
consuming and requires a larger facility. 
Finally, in order to provide more evidence that resuscitative factors are not based 
of amino acids, samples for the BCA assay should be purified from the potential 
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interfering agents. Other important macromolecules to consider for investigation are 
nucleotides, cyclic nucleotides and carbohydrates. 
The present study yielded data that is suggesting that lipids, particularly mycolic 
acids, might have resuscitative properties found in SDCM. It is plausible to speculate on 
lipid involvement based on size, peaks in absorbance spectrum, disappearance of 
resuscitative effect at higher concentrations of SDCM, and TLC data. Nevertheless, 
further work is required in order to test this hypothesis. Extraction of mycolic acids from 
TLC plates, purification, and analysis with mass spectrometry could provide valuable 
data. Preparative HPLC and isolation of lipid components from the low molecular 
fraction of SDCM can be used for direct testing of resuscitative effect using a modified 
protocol addressing the issues mentioned above. If lipids indeed are the ones responsible 
for resuscitative effect of SDCM, more questions arise regarding the pathway they act on. 
Do they directly promote growth and recovery from the dormant state or are they a part 
of a cascade? If part of the cascade, which molecule is the key component of it and what 
is the optimal dose for resuscitative effect? 
 If identified, resuscitative factors found in SDCM can be bioengineered and 
supplemented to the growth media used for diagnostic fecal culture resulting in a higher 
sensitivity of the method. Therefore, it is hoped that the findings of the present study 
contributed to the improvement of diagnosis of Johne’s disease and, sequentially, its 
better management. This, in turn, will lessen financial losses associated with JD, improve 
the quality of dairy products, and possibly improve the management of autoimmune 
disorders associated with MAP infection in human population. 
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APPENDIX 
  
 
 
A1. Optimization of viability assay using flow cytometry. Log green fluorescence vs. 
log red fluorescence for MAP culture suspensions with 100%, 75%, 50%, 25%, and 0% 
viable cells mixed with SYTO9 and PI at equal proportions shown in panels A, B, C, D, 
E, respectively. Blue depicts viable cells stained with SYTO9 only. Green depicts dead 
cells stained with PI and SYTO9. 
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Table A1. Percentage of acquired by flow cytometry live cells compared to predicted 
values. 
Predicted Live 
Cells, % 
 
Acquired Live Cells, % 
Sample 1 Sample 2 Sample 3 Sample 4 
100 67.68 80.96 81.2 83.44 
75 53.11 59.34 63.32 66.38 
50 36.25 41.06 41.62 49.04 
25 16.61 19.3 22.18 27.02 
0 0.83 1.46 2.26 0.68 
 
Percentage of viable cells in each suspension of samples 1, 2, 3, 4 mixed with equal 
proportions of SYTO9 and PI. Data acquired from flow cytometry log green fluorescence 
vs. log red fluorescence plots from experiment set up described in figure A1 repeated in 
quadruplicate. 
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A2. Generation of standard curve and equation of the line for cell viability 
assessment via flow cytometry. Scatter plot of values of viable cells in a suspension (%) 
acquired via flow cytometry for each suspension of samples 1, 2, 3, 4 plotted against 
predicted values. Dotted lines represent linear trend lines for each data set. Solid line 
represents trend line for predicted values. 
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A3. Viability assay of starvation-dormant MAP cells. Blue cells represent viable cells, 
green – dead cells, red and pink – understained cells.  
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A4. Viability assay of anaerobically-dormant MAP cells. Cells were stained with 
SYTO9:PI mixed in equal proportions. Blue cells represent viable cells, green – dead 
cells, red and pink – understained cells.  Panels A, B, and C represent one-year-old 
anaerobically dormant cultures, panel D represents three-months-old anaerobically 
dormant culture. A. Viable cells – 58.79%. B. Viable cells – 54.29%. C. Viable cells – 
22.54%. D. Viable cells – 80.52%. 
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A5. Absorbance spectrum of the low molecular weight fraction of SDCM. Low 
molecular weight fraction of M7H9C growth medium supplemented with OADC was 
used as to blank spectrophotometer. One hundred microliters of the low molecular weight 
fraction of SDCM was screened across absorbance spectrum generating blue line. .One 
hundred microliters of diluted 1:10 low molecular weight fraction of SDCM was 
screened across absorbance spectrum generating red line. 
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A6. Standard curve and equation of the line generated for Biuret assay. Duplicates 
of solutions of bovine serum albumin concentrations ranging from 0 to 0.5 mg/ml and 
Biuret reagent were prepared and incubated at room temperature for 20 minutes. 
Absorbance at 540nm was measured by spectrophotometer.  
Table A2. Protein concentration in low molecular weight fractions of SDCM and 
ADCM determined by Biuret assay. 
Sample # 
Absorbance, 
540nm 
[Protein], mg/ml 
T1 0.047 0.19 
T2 0.053 0.24 
T3 0.031 0.05 
T4 0.062 0.31 
T5 0.049 0.20 
T6 0.056 0.26 
T7 0.041 0.14 
ADCM  12 0.043 0.15 
ADCM 3 0.028 0.03 
y = 0.12x + 0.0248 
R² = 0.7144 
0
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A7. Silver staining of SDS-PAGE gel with 10X concentrates of low molecular weight 
fractions of SDCM, ADCM, M7H9C growth media, and high molecular weight 
fraction of SDCM. Low molecular weight fractions of SDCM from T1, T2, T3, T4, T7, 
of ADCM from one-year-old cultures, and M7H9C growth media were lyophilized and 
resuspended in smaller volume in order to generate 10X concentrates. The samples were 
loaded on SDS-PAGE gels using Orange G loading dye. The samples were stained with 
silver nitrate in order to reveal proteins. L – protein standard ladder; T1, T2, T3, T4, T7 
– low molecular weight fractions of SDCM; A3 - low molecular weight fractions of 
anaerobically-dormant conditioned media from three-month-old culture; C – high 
molecular weight fraction of SDCM containing molecules above 5kDa in size; M - low 
molecular weight fractions of M7H9C growth medium supplemented with OADC. 
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A8. Coomassie Blue staining of SDS-PAGE gel with 10X concentrates of low 
molecular weight fractions of SDCM, ADCM, M7H9C growth media, and high 
molecular weight fraction of SDCM. Low molecular weight fractions of SDCM from 
T1, T2, T3, T4, T7, of ADCM from three-month-old culture, and of M7H9C growth 
media were lyophilized and resuspended in smaller volume in order to generate 10X 
concentrates. The samples were loaded on SDS-PAGE gels using Orange G loading dye. 
The samples were stained with Coomassie Blue stain in order to reveal proteins. L – 
protein standard ladder; T1, T2, T3, T4, T7 – low molecular weight fractions of SDCM; 
A3 - low molecular weight fractions of anaerobically-dormant conditioned media from 
three-month-old culture; C – high molecular weight fraction of SDCM containing 
molecules above 5kDa in size; M - low molecular weight fractions of M7H9C growth 
medium supplemented with OADC.  
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